JP2024506028A - Hydrating oral care compositions containing peroxide - Google Patents
Hydrating oral care compositions containing peroxide Download PDFInfo
- Publication number
- JP2024506028A JP2024506028A JP2023547519A JP2023547519A JP2024506028A JP 2024506028 A JP2024506028 A JP 2024506028A JP 2023547519 A JP2023547519 A JP 2023547519A JP 2023547519 A JP2023547519 A JP 2023547519A JP 2024506028 A JP2024506028 A JP 2024506028A
- Authority
- JP
- Japan
- Prior art keywords
- oral care
- peroxide
- care composition
- zinc
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 388
- 150000002978 peroxides Chemical class 0.000 title claims abstract description 156
- 230000000887 hydrating effect Effects 0.000 title claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 76
- 239000000551 dentifrice Substances 0.000 claims abstract description 43
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical group OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 48
- 239000012071 phase Substances 0.000 claims description 45
- -1 sodium alkyl sulfate Chemical class 0.000 claims description 42
- 229920000642 polymer Polymers 0.000 claims description 36
- 229940024606 amino acid Drugs 0.000 claims description 35
- 235000001014 amino acid Nutrition 0.000 claims description 35
- 150000001413 amino acids Chemical class 0.000 claims description 35
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 33
- 210000000214 mouth Anatomy 0.000 claims description 33
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 claims description 32
- 239000000839 emulsion Substances 0.000 claims description 32
- 239000007764 o/w emulsion Substances 0.000 claims description 29
- 229940091249 fluoride supplement Drugs 0.000 claims description 27
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 26
- 230000002209 hydrophobic effect Effects 0.000 claims description 25
- 150000003839 salts Chemical class 0.000 claims description 19
- 235000002639 sodium chloride Nutrition 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 16
- 239000004094 surface-active agent Substances 0.000 claims description 16
- 239000008346 aqueous phase Substances 0.000 claims description 15
- 239000003995 emulsifying agent Substances 0.000 claims description 15
- 229910052751 metal Inorganic materials 0.000 claims description 15
- 239000002184 metal Substances 0.000 claims description 15
- 239000011701 zinc Substances 0.000 claims description 15
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 14
- 229910052718 tin Inorganic materials 0.000 claims description 14
- 229910052725 zinc Inorganic materials 0.000 claims description 14
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims description 13
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 13
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 claims description 13
- 229960002799 stannous fluoride Drugs 0.000 claims description 13
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 claims description 12
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 11
- 239000000377 silicon dioxide Substances 0.000 claims description 11
- 239000011135 tin Substances 0.000 claims description 11
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 10
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 10
- 239000011575 calcium Substances 0.000 claims description 10
- 229910052791 calcium Inorganic materials 0.000 claims description 10
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 claims description 9
- 239000001506 calcium phosphate Substances 0.000 claims description 9
- 229960004711 sodium monofluorophosphate Drugs 0.000 claims description 9
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 9
- 239000003945 anionic surfactant Substances 0.000 claims description 8
- 239000000606 toothpaste Substances 0.000 claims description 8
- 229940034610 toothpaste Drugs 0.000 claims description 8
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 claims description 8
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 claims description 7
- 239000004471 Glycine Substances 0.000 claims description 7
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 7
- 229910021626 Tin(II) chloride Inorganic materials 0.000 claims description 7
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 7
- 235000004554 glutamine Nutrition 0.000 claims description 7
- 239000001119 stannous chloride Substances 0.000 claims description 7
- 235000011150 stannous chloride Nutrition 0.000 claims description 7
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 claims description 7
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims description 6
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 6
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims description 6
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 6
- 235000009582 asparagine Nutrition 0.000 claims description 6
- 229960001230 asparagine Drugs 0.000 claims description 6
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 claims description 6
- 239000011775 sodium fluoride Substances 0.000 claims description 6
- 235000013024 sodium fluoride Nutrition 0.000 claims description 6
- 229960000414 sodium fluoride Drugs 0.000 claims description 6
- LRXTYHSAJDENHV-UHFFFAOYSA-H zinc phosphate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O LRXTYHSAJDENHV-UHFFFAOYSA-H 0.000 claims description 6
- 229910000165 zinc phosphate Inorganic materials 0.000 claims description 6
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 5
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 5
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 5
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 5
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 5
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 5
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 5
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 5
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 5
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 5
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 5
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 5
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 5
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 5
- 239000004473 Threonine Substances 0.000 claims description 5
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 5
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 5
- 235000004279 alanine Nutrition 0.000 claims description 5
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 5
- 235000010216 calcium carbonate Nutrition 0.000 claims description 5
- 229910000389 calcium phosphate Inorganic materials 0.000 claims description 5
- 235000011010 calcium phosphates Nutrition 0.000 claims description 5
- 229920001577 copolymer Polymers 0.000 claims description 5
- 229910052802 copper Inorganic materials 0.000 claims description 5
- 239000010949 copper Substances 0.000 claims description 5
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 5
- 235000018417 cysteine Nutrition 0.000 claims description 5
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 5
- 229960000310 isoleucine Drugs 0.000 claims description 5
- 229930182817 methionine Natural products 0.000 claims description 5
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 5
- 229920000136 polysorbate Polymers 0.000 claims description 5
- 235000004400 serine Nutrition 0.000 claims description 5
- 235000008521 threonine Nutrition 0.000 claims description 5
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 claims description 5
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 5
- 239000004474 valine Substances 0.000 claims description 5
- 239000011746 zinc citrate Substances 0.000 claims description 5
- 235000006076 zinc citrate Nutrition 0.000 claims description 5
- 229940068475 zinc citrate Drugs 0.000 claims description 5
- 239000011787 zinc oxide Substances 0.000 claims description 5
- 239000004343 Calcium peroxide Substances 0.000 claims description 4
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- LHJQIRIGXXHNLA-UHFFFAOYSA-N calcium peroxide Chemical compound [Ca+2].[O-][O-] LHJQIRIGXXHNLA-UHFFFAOYSA-N 0.000 claims description 4
- 235000019402 calcium peroxide Nutrition 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- PFUVRDFDKPNGAV-UHFFFAOYSA-N sodium peroxide Chemical compound [Na+].[Na+].[O-][O-] PFUVRDFDKPNGAV-UHFFFAOYSA-N 0.000 claims description 4
- 239000011592 zinc chloride Substances 0.000 claims description 4
- 235000005074 zinc chloride Nutrition 0.000 claims description 4
- 239000011576 zinc lactate Substances 0.000 claims description 4
- 235000000193 zinc lactate Nutrition 0.000 claims description 4
- 229940050168 zinc lactate Drugs 0.000 claims description 4
- FDKWRPBBCBCIGA-REOHCLBHSA-N (2r)-2-azaniumyl-3-$l^{1}-selanylpropanoate Chemical compound [Se]C[C@H](N)C(O)=O FDKWRPBBCBCIGA-REOHCLBHSA-N 0.000 claims description 3
- BLCJBICVQSYOIF-UHFFFAOYSA-N 2,2-diaminobutanoic acid Chemical compound CCC(N)(N)C(O)=O BLCJBICVQSYOIF-UHFFFAOYSA-N 0.000 claims description 3
- XHZPRMZZQOIPDS-UHFFFAOYSA-N 2-Methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(C)(C)NC(=O)C=C XHZPRMZZQOIPDS-UHFFFAOYSA-N 0.000 claims description 3
- PECYZEOJVXMISF-UHFFFAOYSA-N 3-aminoalanine Chemical compound [NH3+]CC(N)C([O-])=O PECYZEOJVXMISF-UHFFFAOYSA-N 0.000 claims description 3
- 239000004475 Arginine Substances 0.000 claims description 3
- FDKWRPBBCBCIGA-UWTATZPHSA-N D-Selenocysteine Natural products [Se]C[C@@H](N)C(O)=O FDKWRPBBCBCIGA-UWTATZPHSA-N 0.000 claims description 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 3
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims description 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 3
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 3
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 claims description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 3
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 3
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 3
- 239000004472 Lysine Substances 0.000 claims description 3
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 claims description 3
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 claims description 3
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 claims description 3
- 150000008051 alkyl sulfates Chemical class 0.000 claims description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 3
- 235000009697 arginine Nutrition 0.000 claims description 3
- 235000003704 aspartic acid Nutrition 0.000 claims description 3
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 3
- 229960002173 citrulline Drugs 0.000 claims description 3
- 235000013477 citrulline Nutrition 0.000 claims description 3
- 229960003624 creatine Drugs 0.000 claims description 3
- 239000006046 creatine Substances 0.000 claims description 3
- 229920006037 cross link polymer Polymers 0.000 claims description 3
- 235000013922 glutamic acid Nutrition 0.000 claims description 3
- 239000004220 glutamic acid Substances 0.000 claims description 3
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 3
- 235000014304 histidine Nutrition 0.000 claims description 3
- 235000018977 lysine Nutrition 0.000 claims description 3
- 229960003104 ornithine Drugs 0.000 claims description 3
- 229940055619 selenocysteine Drugs 0.000 claims description 3
- ZKZBPNGNEQAJSX-UHFFFAOYSA-N selenocysteine Natural products [SeH]CC(N)C(O)=O ZKZBPNGNEQAJSX-UHFFFAOYSA-N 0.000 claims description 3
- 235000016491 selenocysteine Nutrition 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- 239000004264 Petrolatum Substances 0.000 claims description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 2
- 229940066842 petrolatum Drugs 0.000 claims description 2
- 235000019271 petrolatum Nutrition 0.000 claims description 2
- 229950008882 polysorbate Drugs 0.000 claims description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims 3
- 229940078916 carbamide peroxide Drugs 0.000 claims 3
- VTIIJXUACCWYHX-UHFFFAOYSA-L disodium;carboxylatooxy carbonate Chemical compound [Na+].[Na+].[O-]C(=O)OOC([O-])=O VTIIJXUACCWYHX-UHFFFAOYSA-L 0.000 claims 3
- DLINORNFHVEIFE-UHFFFAOYSA-N hydrogen peroxide;zinc Chemical compound [Zn].OO DLINORNFHVEIFE-UHFFFAOYSA-N 0.000 claims 3
- 229960001245 olaflur Drugs 0.000 claims 3
- ZVVSSOQAYNYNPP-UHFFFAOYSA-N olaflur Chemical compound F.F.CCCCCCCCCCCCCCCCCCN(CCO)CCCN(CCO)CCO ZVVSSOQAYNYNPP-UHFFFAOYSA-N 0.000 claims 3
- 229940045872 sodium percarbonate Drugs 0.000 claims 3
- 229940105296 zinc peroxide Drugs 0.000 claims 3
- 229920000536 2-Acrylamido-2-methylpropane sulfonic acid Polymers 0.000 claims 2
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 claims 2
- 239000007762 w/o emulsion Substances 0.000 claims 2
- 229960001939 zinc chloride Drugs 0.000 claims 2
- 229960001296 zinc oxide Drugs 0.000 claims 2
- 229940077935 zinc phosphate Drugs 0.000 claims 2
- 229910021653 sulphate ion Inorganic materials 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 22
- 239000004615 ingredient Substances 0.000 description 21
- 239000003082 abrasive agent Substances 0.000 description 20
- 150000001875 compounds Chemical class 0.000 description 20
- 238000000502 dialysis Methods 0.000 description 20
- 229920000388 Polyphosphate Polymers 0.000 description 18
- 239000001205 polyphosphate Substances 0.000 description 18
- 235000011176 polyphosphates Nutrition 0.000 description 18
- 239000002562 thickening agent Substances 0.000 description 16
- 125000005233 alkylalcohol group Chemical group 0.000 description 15
- 238000009472 formulation Methods 0.000 description 15
- 238000012360 testing method Methods 0.000 description 14
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 12
- 229940043256 calcium pyrophosphate Drugs 0.000 description 12
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 12
- 239000003906 humectant Substances 0.000 description 11
- 229910021645 metal ion Inorganic materials 0.000 description 11
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 11
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 10
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 10
- 230000007935 neutral effect Effects 0.000 description 10
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 10
- 239000003795 chemical substances by application Substances 0.000 description 9
- 150000001991 dicarboxylic acids Chemical class 0.000 description 9
- 239000002324 mouth wash Substances 0.000 description 9
- 229910001432 tin ion Inorganic materials 0.000 description 9
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 8
- 229920001525 carrageenan Polymers 0.000 description 8
- 239000000796 flavoring agent Substances 0.000 description 8
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 8
- BHHYHSUAOQUXJK-UHFFFAOYSA-L zinc fluoride Chemical class F[Zn]F BHHYHSUAOQUXJK-UHFFFAOYSA-L 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 7
- 239000000679 carrageenan Substances 0.000 description 7
- 229940113118 carrageenan Drugs 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- 230000002087 whitening effect Effects 0.000 description 7
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid group Chemical group C(CC(O)(C(=O)O)CC(=O)O)(=O)O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000003086 colorant Substances 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- 241000628997 Flos Species 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 239000013543 active substance Substances 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 235000010418 carrageenan Nutrition 0.000 description 5
- 229960000541 cetyl alcohol Drugs 0.000 description 5
- 239000002537 cosmetic Substances 0.000 description 5
- 235000013355 food flavoring agent Nutrition 0.000 description 5
- 150000004676 glycans Chemical class 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 5
- 229920001282 polysaccharide Polymers 0.000 description 5
- 239000005017 polysaccharide Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 4
- 229910019142 PO4 Inorganic materials 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 4
- 239000007844 bleaching agent Substances 0.000 description 4
- 229940098130 colgate optic white Drugs 0.000 description 4
- 238000009792 diffusion process Methods 0.000 description 4
- 235000003599 food sweetener Nutrition 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 150000002739 metals Chemical class 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 239000010452 phosphate Substances 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 4
- 230000009257 reactivity Effects 0.000 description 4
- 239000003765 sweetening agent Substances 0.000 description 4
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 4
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical class [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 125000000129 anionic group Chemical group 0.000 description 3
- 229920002678 cellulose Chemical class 0.000 description 3
- 239000001913 cellulose Chemical class 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- 238000010668 complexation reaction Methods 0.000 description 3
- 239000002826 coolant Substances 0.000 description 3
- 125000004122 cyclic group Chemical group 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 239000006260 foam Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- XPFVYQJUAUNWIW-UHFFFAOYSA-N furfuryl alcohol Chemical compound OCC1=CC=CO1 XPFVYQJUAUNWIW-UHFFFAOYSA-N 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 239000006072 paste Substances 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 229940071089 sarcosinate Drugs 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 239000002002 slurry Substances 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000004408 titanium dioxide Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- OOCCDEMITAIZTP-QPJJXVBHSA-N (E)-cinnamyl alcohol Chemical compound OC\C=C\C1=CC=CC=C1 OOCCDEMITAIZTP-QPJJXVBHSA-N 0.000 description 2
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- BBMCTIGTTCKYKF-UHFFFAOYSA-N 1-heptanol Chemical compound CCCCCCCO BBMCTIGTTCKYKF-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- PKBSGDQYUYBUDY-UHFFFAOYSA-N 1-nonacosanol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCO PKBSGDQYUYBUDY-UHFFFAOYSA-N 0.000 description 2
- NGOZDSMNMIRDFP-UHFFFAOYSA-N 2-[methyl(tetradecanoyl)amino]acetic acid Chemical compound CCCCCCCCCCCCCC(=O)N(C)CC(O)=O NGOZDSMNMIRDFP-UHFFFAOYSA-N 0.000 description 2
- YIWUKEYIRIRTPP-UHFFFAOYSA-N 2-ethylhexan-1-ol Chemical compound CCCCC(CC)CO YIWUKEYIRIRTPP-UHFFFAOYSA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- 244000215068 Acacia senegal Species 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 241001474374 Blennius Species 0.000 description 2
- 206010006326 Breath odour Diseases 0.000 description 2
- 241000195940 Bryophyta Species 0.000 description 2
- 239000004132 Calcium polyphosphate Substances 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 2
- VUNOFAIHSALQQH-UHFFFAOYSA-N Ethyl menthane carboxamide Chemical compound CCNC(=O)C1CC(C)CCC1C(C)C VUNOFAIHSALQQH-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- BACYUWVYYTXETD-UHFFFAOYSA-N N-Lauroylsarcosine Chemical compound CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 239000004376 Sucralose Substances 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- ZNOZWUKQPJXOIG-XSBHQQIPSA-L [(2r,3s,4r,5r,6s)-6-[[(1r,3s,4r,5r,8s)-3,4-dihydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]-4-[[(1r,3r,4r,5r,8s)-8-[(2s,3r,4r,5r,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-2-yl]oxy-4-hydroxy-2,6-dioxabicyclo[3.2.1]octan-3-yl]oxy]-5-hydroxy-2-( Chemical compound O[C@@H]1[C@@H](O)[C@@H](OS([O-])(=O)=O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H]2OC[C@H]1O[C@H](O[C@H]1[C@H]([C@@H](CO)O[C@@H](O[C@@H]3[C@@H]4OC[C@H]3O[C@H](O)[C@@H]4O)[C@@H]1O)OS([O-])(=O)=O)[C@@H]2O ZNOZWUKQPJXOIG-XSBHQQIPSA-L 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- XXROGKLTLUQVRX-UHFFFAOYSA-N allyl alcohol Chemical compound OCC=C XXROGKLTLUQVRX-UHFFFAOYSA-N 0.000 description 2
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 2
- ROPDWRCJTIRLTR-UHFFFAOYSA-L calcium metaphosphate Chemical compound [Ca+2].[O-]P(=O)=O.[O-]P(=O)=O ROPDWRCJTIRLTR-UHFFFAOYSA-L 0.000 description 2
- 235000019827 calcium polyphosphate Nutrition 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- MRUAUOIMASANKQ-UHFFFAOYSA-O carboxymethyl-[3-(dodecanoylamino)propyl]-dimethylazanium Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(O)=O MRUAUOIMASANKQ-UHFFFAOYSA-O 0.000 description 2
- 239000012876 carrier material Substances 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 239000007910 chewable tablet Substances 0.000 description 2
- 229940112822 chewing gum Drugs 0.000 description 2
- 235000015218 chewing gum Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000004927 clay Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 210000004268 dentin Anatomy 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 2
- 229940038472 dicalcium phosphate Drugs 0.000 description 2
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 2
- 235000011180 diphosphates Nutrition 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 239000008157 edible vegetable oil Substances 0.000 description 2
- CBOQJANXLMLOSS-UHFFFAOYSA-N ethyl vanillin Chemical compound CCOC1=CC(C=O)=CC=C1O CBOQJANXLMLOSS-UHFFFAOYSA-N 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 150000002222 fluorine compounds Chemical class 0.000 description 2
- 229910021485 fumed silica Inorganic materials 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 150000002334 glycols Chemical class 0.000 description 2
- 230000007407 health benefit Effects 0.000 description 2
- FIPPFBHCBUDBRR-UHFFFAOYSA-N henicosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCO FIPPFBHCBUDBRR-UHFFFAOYSA-N 0.000 description 2
- ULCZGKYHRYJXAU-UHFFFAOYSA-N heptacosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCO ULCZGKYHRYJXAU-UHFFFAOYSA-N 0.000 description 2
- IRHTZOCLLONTOC-UHFFFAOYSA-N hexacosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCO IRHTZOCLLONTOC-UHFFFAOYSA-N 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- 150000004677 hydrates Chemical class 0.000 description 2
- BTFJIXJJCSYFAL-UHFFFAOYSA-N icosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- 235000010494 karaya gum Nutrition 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 239000007937 lozenge Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 2
- 229910052748 manganese Inorganic materials 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 229910052750 molybdenum Inorganic materials 0.000 description 2
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 2
- 235000011929 mousse Nutrition 0.000 description 2
- KPSSIOMAKSHJJG-UHFFFAOYSA-N neopentyl alcohol Chemical compound CC(C)(C)CO KPSSIOMAKSHJJG-UHFFFAOYSA-N 0.000 description 2
- ZWRUINPWMLAQRD-UHFFFAOYSA-N nonan-1-ol Chemical compound CCCCCCCCCO ZWRUINPWMLAQRD-UHFFFAOYSA-N 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- CNNRPFQICPFDPO-UHFFFAOYSA-N octacosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCO CNNRPFQICPFDPO-UHFFFAOYSA-N 0.000 description 2
- 150000003891 oxalate salts Chemical class 0.000 description 2
- 235000006408 oxalic acid Nutrition 0.000 description 2
- CFJYNSNXFXLKNS-UHFFFAOYSA-N p-menthane Chemical compound CC(C)C1CCC(C)CC1 CFJYNSNXFXLKNS-UHFFFAOYSA-N 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- IACKKVBKKNJZGN-UHFFFAOYSA-N pentacosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCO IACKKVBKKNJZGN-UHFFFAOYSA-N 0.000 description 2
- NDTYTMIUWGWIMO-UHFFFAOYSA-N perillyl alcohol Chemical compound CC(=C)C1CCC(CO)=CC1 NDTYTMIUWGWIMO-UHFFFAOYSA-N 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 2
- WLJVNTCWHIRURA-UHFFFAOYSA-N pimelic acid Chemical compound OC(=O)CCCCCC(O)=O WLJVNTCWHIRURA-UHFFFAOYSA-N 0.000 description 2
- 238000005498 polishing Methods 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 229940068965 polysorbates Drugs 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical class [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 2
- 239000011698 potassium fluoride Substances 0.000 description 2
- 235000003270 potassium fluoride Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 108700004121 sarkosyl Proteins 0.000 description 2
- CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical compound OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 229940079781 sodium cocoyl glutamate Drugs 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- TYFQFVWCELRYAO-UHFFFAOYSA-N suberic acid Chemical compound OC(=O)CCCCCCC(O)=O TYFQFVWCELRYAO-UHFFFAOYSA-N 0.000 description 2
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 2
- 235000019408 sucralose Nutrition 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- TYWMIZZBOVGFOV-UHFFFAOYSA-N tetracosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCO TYWMIZZBOVGFOV-UHFFFAOYSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- IUTCEZPPWBHGIX-UHFFFAOYSA-N tin(2+) Chemical compound [Sn+2] IUTCEZPPWBHGIX-UHFFFAOYSA-N 0.000 description 2
- ZSUXOVNWDZTCFN-UHFFFAOYSA-L tin(ii) bromide Chemical compound Br[Sn]Br ZSUXOVNWDZTCFN-UHFFFAOYSA-L 0.000 description 2
- JTDNNCYXCFHBGG-UHFFFAOYSA-L tin(ii) iodide Chemical compound I[Sn]I JTDNNCYXCFHBGG-UHFFFAOYSA-L 0.000 description 2
- QHGNHLZPVBIIPX-UHFFFAOYSA-N tin(ii) oxide Chemical compound [Sn]=O QHGNHLZPVBIIPX-UHFFFAOYSA-N 0.000 description 2
- QPBYLOWPSRZOFX-UHFFFAOYSA-J tin(iv) iodide Chemical compound I[Sn](I)(I)I QPBYLOWPSRZOFX-UHFFFAOYSA-J 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- 229940078499 tricalcium phosphate Drugs 0.000 description 2
- 235000019731 tricalcium phosphate Nutrition 0.000 description 2
- FPLNRAYTBIFSFW-UHFFFAOYSA-N tricosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCO FPLNRAYTBIFSFW-UHFFFAOYSA-N 0.000 description 2
- MBBOMCVGYCRMEA-UHFFFAOYSA-N tryptophol Chemical compound C1=CC=C2C(CCO)=CNC2=C1 MBBOMCVGYCRMEA-UHFFFAOYSA-N 0.000 description 2
- LWBHHRRTOZQPDM-UHFFFAOYSA-N undecanedioic acid Chemical compound OC(=O)CCCCCCCCCC(O)=O LWBHHRRTOZQPDM-UHFFFAOYSA-N 0.000 description 2
- ZENOXNGFMSCLLL-UHFFFAOYSA-N vanillyl alcohol Chemical compound COC1=CC(CO)=CC=C1O ZENOXNGFMSCLLL-UHFFFAOYSA-N 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- 229930007631 (-)-perillyl alcohol Natural products 0.000 description 1
- PXLKJWMSFPYVNB-UHFFFAOYSA-N (1-methyl-4-propan-2-ylcyclohexyl) acetate Chemical compound CC(C)C1CCC(C)(OC(C)=O)CC1 PXLKJWMSFPYVNB-UHFFFAOYSA-N 0.000 description 1
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UWTATZPHSA-M (R)-lactate Chemical compound C[C@@H](O)C([O-])=O JVTAAEKCZFNVCJ-UWTATZPHSA-M 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical class FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- OQBLGYCUQGDOOR-UHFFFAOYSA-L 1,3,2$l^{2}-dioxastannolane-4,5-dione Chemical compound O=C1O[Sn]OC1=O OQBLGYCUQGDOOR-UHFFFAOYSA-L 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical class CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- 229960002666 1-octacosanol Drugs 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 229940094997 1-tetracosanol Drugs 0.000 description 1
- QFGCFKJIPBRJGM-UHFFFAOYSA-N 12-[(2-methylpropan-2-yl)oxy]-12-oxododecanoic acid Chemical compound CC(C)(C)OC(=O)CCCCCCCCCCC(O)=O QFGCFKJIPBRJGM-UHFFFAOYSA-N 0.000 description 1
- DBHODFSFBXJZNY-UHFFFAOYSA-N 2,4-dichlorobenzyl alcohol Chemical compound OCC1=CC=C(Cl)C=C1Cl DBHODFSFBXJZNY-UHFFFAOYSA-N 0.000 description 1
- PWVUXRBUUYZMKM-UHFFFAOYSA-N 2-(2-hydroxyethoxy)ethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOCCO PWVUXRBUUYZMKM-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- WCASXYBKJHWFMY-NSCUHMNNSA-N 2-Buten-1-ol Chemical compound C\C=C\CO WCASXYBKJHWFMY-NSCUHMNNSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- LFJJOPDNPVFCNZ-UHFFFAOYSA-N 2-[hexadecanoyl(methyl)amino]acetic acid Chemical compound CCCCCCCCCCCCCCCC(=O)N(C)CC(O)=O LFJJOPDNPVFCNZ-UHFFFAOYSA-N 0.000 description 1
- CLWNPUARORRDFD-UHFFFAOYSA-N 2-hydroxybutanedioic acid;zinc Chemical compound [Zn].OC(=O)C(O)CC(O)=O CLWNPUARORRDFD-UHFFFAOYSA-N 0.000 description 1
- BHIZVZJETFVJMJ-UHFFFAOYSA-N 2-hydroxypropyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(C)O BHIZVZJETFVJMJ-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- CDOUZKKFHVEKRI-UHFFFAOYSA-N 3-bromo-n-[(prop-2-enoylamino)methyl]propanamide Chemical compound BrCCC(=O)NCNC(=O)C=C CDOUZKKFHVEKRI-UHFFFAOYSA-N 0.000 description 1
- CWNPOQFCIIFQDM-UHFFFAOYSA-N 3-nitrobenzyl alcohol Chemical compound OCC1=CC=CC([N+]([O-])=O)=C1 CWNPOQFCIIFQDM-UHFFFAOYSA-N 0.000 description 1
- MVQVNTPHUGQQHK-UHFFFAOYSA-N 3-pyridinemethanol Chemical compound OCC1=CC=CN=C1 MVQVNTPHUGQQHK-UHFFFAOYSA-N 0.000 description 1
- MSHFRERJPWKJFX-UHFFFAOYSA-N 4-Methoxybenzyl alcohol Chemical compound COC1=CC=C(CO)C=C1 MSHFRERJPWKJFX-UHFFFAOYSA-N 0.000 description 1
- OZJPLYNZGCXSJM-UHFFFAOYSA-N 5-valerolactone Chemical compound O=C1CCCCO1 OZJPLYNZGCXSJM-UHFFFAOYSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- 235000006491 Acacia senegal Nutrition 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 229910002012 Aerosil® Inorganic materials 0.000 description 1
- 229920001817 Agar Chemical class 0.000 description 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-M Aminoacetate Chemical compound NCC([O-])=O DHMQDGOQFOQNFH-UHFFFAOYSA-M 0.000 description 1
- 244000153158 Ammi visnaga Species 0.000 description 1
- 235000010585 Ammi visnaga Nutrition 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- PTHCMJGKKRQCBF-UHFFFAOYSA-N Cellulose, microcrystalline Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC)C(CO)O1 PTHCMJGKKRQCBF-UHFFFAOYSA-N 0.000 description 1
- 229910052684 Cerium Inorganic materials 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 229940090898 Desensitizer Drugs 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- QSJXEFYPDANLFS-UHFFFAOYSA-N Diacetyl Chemical group CC(=O)C(C)=O QSJXEFYPDANLFS-UHFFFAOYSA-N 0.000 description 1
- 239000004129 EU approved improving agent Substances 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 239000001329 FEMA 3811 Substances 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 229930183419 Irisone Natural products 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- ILRKKHJEINIICQ-OOFFSTKBSA-N Monoammonium glycyrrhizinate Chemical compound N.O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O ILRKKHJEINIICQ-OOFFSTKBSA-N 0.000 description 1
- GWRCTWAPTXBPHW-UHFFFAOYSA-N N-[(Ethoxycarbonyl)methyl)-p-menthane-3-carboxamide Chemical compound CCOC(=O)CNC(=O)C1CC(C)CCC1C(C)C GWRCTWAPTXBPHW-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- MXRIRQGCELJRSN-UHFFFAOYSA-N O.O.O.[Al] Chemical compound O.O.O.[Al] MXRIRQGCELJRSN-UHFFFAOYSA-N 0.000 description 1
- 235000011203 Origanum Nutrition 0.000 description 1
- 240000000783 Origanum majorana Species 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-L Oxalate Chemical compound [O-]C(=O)C([O-])=O MUBZPKHOEPUJKR-UHFFFAOYSA-L 0.000 description 1
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 1
- 229920000604 Polyethylene Glycol 200 Polymers 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 239000004147 Sorbitan trioleate Chemical class 0.000 description 1
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical class CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 229910021623 Tin(IV) bromide Inorganic materials 0.000 description 1
- 229910021627 Tin(IV) chloride Inorganic materials 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- FMRLDPWIRHBCCC-UHFFFAOYSA-L Zinc carbonate Chemical compound [Zn+2].[O-]C([O-])=O FMRLDPWIRHBCCC-UHFFFAOYSA-L 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- FGUZFFWTBWJBIL-XWVZOOPGSA-N [(1r)-1-[(2s,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)O[C@H](CO)[C@H]1OC[C@H](O)[C@H]1O FGUZFFWTBWJBIL-XWVZOOPGSA-N 0.000 description 1
- IJCWFDPJFXGQBN-RYNSOKOISA-N [(2R)-2-[(2R,3R,4S)-4-hydroxy-3-octadecanoyloxyoxolan-2-yl]-2-octadecanoyloxyethyl] octadecanoate Chemical class CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCCCCCCCCCCCC IJCWFDPJFXGQBN-RYNSOKOISA-N 0.000 description 1
- LWZFANDGMFTDAV-BURFUSLBSA-N [(2r)-2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O LWZFANDGMFTDAV-BURFUSLBSA-N 0.000 description 1
- FOLJTMYCYXSPFQ-CJKAUBRRSA-N [(2r,3s,4s,5r,6r)-6-[(2s,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)-2-(octadecanoyloxymethyl)oxolan-2-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl octadecanoate Chemical class O[C@@H]1[C@@H](O)[C@H](O)[C@@H](COC(=O)CCCCCCCCCCCCCCCCC)O[C@@H]1O[C@@]1(COC(=O)CCCCCCCCCCCCCCCCC)[C@@H](O)[C@H](O)[C@@H](CO)O1 FOLJTMYCYXSPFQ-CJKAUBRRSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 239000008272 agar Chemical class 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- OOCCDEMITAIZTP-UHFFFAOYSA-N allylic benzylic alcohol Natural products OCC=CC1=CC=CC=C1 OOCCDEMITAIZTP-UHFFFAOYSA-N 0.000 description 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 229940124277 aminobutyric acid Drugs 0.000 description 1
- 229940073143 ammoniated glycyrrhizin Drugs 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000002272 anti-calculus Effects 0.000 description 1
- 230000002882 anti-plaque Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- ZJRXSAYFZMGQFP-UHFFFAOYSA-N barium peroxide Chemical compound [Ba+2].[O-][O-] ZJRXSAYFZMGQFP-UHFFFAOYSA-N 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 229940063013 borate ion Drugs 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 229940006460 bromide ion Drugs 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229960003563 calcium carbonate Drugs 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- NNOYLBKZPCUCQT-UHFFFAOYSA-L calcium;1,1-dioxo-1,2-benzothiazol-3-olate;heptahydrate Chemical compound O.O.O.O.O.O.O.[Ca+2].C1=CC=C2C([O-])=NS(=O)(=O)C2=C1.C1=CC=C2C([O-])=NS(=O)(=O)C2=C1 NNOYLBKZPCUCQT-UHFFFAOYSA-L 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical group 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000009918 complex formation Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000035597 cooling sensation Effects 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 229940109275 cyclamate Drugs 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 201000002170 dentin sensitivity Diseases 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 229960004698 dichlorobenzyl alcohol Drugs 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 235000019329 dioctyl sodium sulphosuccinate Nutrition 0.000 description 1
- LRCFXGAMWKDGLA-UHFFFAOYSA-N dioxosilane;hydrate Chemical compound O.O=[Si]=O LRCFXGAMWKDGLA-UHFFFAOYSA-N 0.000 description 1
- IRXRGVFLQOSHOH-UHFFFAOYSA-L dipotassium;oxalate Chemical compound [K+].[K+].[O-]C(=O)C([O-])=O IRXRGVFLQOSHOH-UHFFFAOYSA-L 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- RDYMFSUJUZBWLH-UHFFFAOYSA-N endosulfan Chemical compound C12COS(=O)OCC2C2(Cl)C(Cl)=C(Cl)C1(Cl)C2(Cl)Cl RDYMFSUJUZBWLH-UHFFFAOYSA-N 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002169 ethanolamines Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 229940073505 ethyl vanillin Drugs 0.000 description 1
- 239000001902 eugenia caryophyllata l. bud oil Substances 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 150000004673 fluoride salts Chemical class 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000005350 fused silica glass Substances 0.000 description 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
- WCASXYBKJHWFMY-UHFFFAOYSA-N gamma-methylallyl alcohol Natural products CC=CCO WCASXYBKJHWFMY-UHFFFAOYSA-N 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
- 125000005908 glyceryl ester group Chemical group 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 239000013003 healing agent Substances 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- QQHJDPROMQRDLA-UHFFFAOYSA-N hexadecanedioic acid Chemical compound OC(=O)CCCCCCCCCCCCCCC(O)=O QQHJDPROMQRDLA-UHFFFAOYSA-N 0.000 description 1
- 229940005740 hexametaphosphate Drugs 0.000 description 1
- 150000002432 hydroperoxides Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- BDAGIHXWWSANSR-NJFSPNSNSA-N hydroxyformaldehyde Chemical compound O[14CH]=O BDAGIHXWWSANSR-NJFSPNSNSA-N 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229910052738 indium Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 description 1
- 229940006461 iodide ion Drugs 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000000832 lactitol Substances 0.000 description 1
- 235000010448 lactitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 229960003451 lactitol Drugs 0.000 description 1
- 229940075468 lauramidopropyl betaine Drugs 0.000 description 1
- 229940071145 lauroyl sarcosinate Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 239000001683 mentha spicata herb oil Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 229940070782 myristoyl sarcosinate Drugs 0.000 description 1
- ITVGXXMINPYUHD-CUVHLRMHSA-N neohesperidin dihydrochalcone Chemical compound C1=C(O)C(OC)=CC=C1CCC(=O)C(C(=C1)O)=C(O)C=C1O[C@H]1[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ITVGXXMINPYUHD-CUVHLRMHSA-N 0.000 description 1
- 229940089953 neohesperidin dihydrochalcone Drugs 0.000 description 1
- 235000010434 neohesperidine DC Nutrition 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229960004738 nicotinyl alcohol Drugs 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 150000001451 organic peroxides Chemical class 0.000 description 1
- BBJSDUUHGVDNKL-UHFFFAOYSA-J oxalate;titanium(4+) Chemical compound [Ti+4].[O-]C(=O)C([O-])=O.[O-]C(=O)C([O-])=O BBJSDUUHGVDNKL-UHFFFAOYSA-J 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- AHKZTVQIVOEVFO-UHFFFAOYSA-N oxide(2-) Chemical compound [O-2] AHKZTVQIVOEVFO-UHFFFAOYSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229930004008 p-menthane Natural products 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 239000010663 parsley oil Substances 0.000 description 1
- 239000001814 pectin Chemical class 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Chemical class 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 235000005693 perillyl alcohol Nutrition 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 239000010451 perlite Substances 0.000 description 1
- 235000019362 perlite Nutrition 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- SATCULPHIDQDRE-UHFFFAOYSA-N piperonal Chemical compound O=CC1=CC=C2OCOC2=C1 SATCULPHIDQDRE-UHFFFAOYSA-N 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229960000502 poloxamer Drugs 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Chemical class 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- JMTCDHVHZSGGJA-UHFFFAOYSA-M potassium hydrogenoxalate Chemical compound [K+].OC(=O)C([O-])=O JMTCDHVHZSGGJA-UHFFFAOYSA-M 0.000 description 1
- HEKURBKACCBNEJ-UHFFFAOYSA-M potassium;1,1-dioxo-1,2-benzothiazol-2-id-3-one Chemical compound [K+].C1=CC=C2C(=O)[N-]S(=O)(=O)C2=C1 HEKURBKACCBNEJ-UHFFFAOYSA-M 0.000 description 1
- 229940088417 precipitated calcium carbonate Drugs 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 150000003138 primary alcohols Chemical class 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- TVDSBUOJIPERQY-UHFFFAOYSA-N prop-2-yn-1-ol Chemical compound OCC#C TVDSBUOJIPERQY-UHFFFAOYSA-N 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229940026235 propylene glycol monolaurate Drugs 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 229940043243 saccharin calcium Drugs 0.000 description 1
- 229940085605 saccharin sodium Drugs 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- CQRYARSYNCAZFO-UHFFFAOYSA-N salicyl alcohol Chemical compound OCC1=CC=CC=C1O CQRYARSYNCAZFO-UHFFFAOYSA-N 0.000 description 1
- 239000001296 salvia officinalis l. Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 150000003333 secondary alcohols Chemical class 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 229960004029 silicic acid Drugs 0.000 description 1
- 239000000661 sodium alginate Chemical class 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 1
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 1
- 229940075560 sodium lauryl sulfoacetate Drugs 0.000 description 1
- ZNCPFRVNHGOPAG-UHFFFAOYSA-L sodium oxalate Chemical compound [Na+].[Na+].[O-]C(=O)C([O-])=O ZNCPFRVNHGOPAG-UHFFFAOYSA-L 0.000 description 1
- 235000019832 sodium triphosphate Nutrition 0.000 description 1
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 description 1
- UJRAXLUXHBUNDO-UHFFFAOYSA-M sodium;hydron;oxalate Chemical compound [Na+].OC(=O)C([O-])=O UJRAXLUXHBUNDO-UHFFFAOYSA-M 0.000 description 1
- 229940057429 sorbitan isostearate Drugs 0.000 description 1
- 229950006451 sorbitan laurate Drugs 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 235000011067 sorbitan monolaureate Nutrition 0.000 description 1
- 235000011071 sorbitan monopalmitate Nutrition 0.000 description 1
- 239000001570 sorbitan monopalmitate Substances 0.000 description 1
- 229940031953 sorbitan monopalmitate Drugs 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 235000019337 sorbitan trioleate Nutrition 0.000 description 1
- 229960000391 sorbitan trioleate Drugs 0.000 description 1
- 239000001589 sorbitan tristearate Chemical class 0.000 description 1
- 235000011078 sorbitan tristearate Nutrition 0.000 description 1
- 229960004129 sorbitan tristearate Drugs 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 235000019721 spearmint oil Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 229940108184 stannous iodide Drugs 0.000 description 1
- RCIVOBGSMSSVTR-UHFFFAOYSA-L stannous sulfate Chemical compound [SnH2+2].[O-]S([O-])(=O)=O RCIVOBGSMSSVTR-UHFFFAOYSA-L 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- 229910000018 strontium carbonate Inorganic materials 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 230000019635 sulfation Effects 0.000 description 1
- 238000005670 sulfation reaction Methods 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 238000007910 systemic administration Methods 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 150000003509 tertiary alcohols Chemical class 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- 239000000892 thaumatin Substances 0.000 description 1
- 235000010436 thaumatin Nutrition 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 150000003606 tin compounds Chemical class 0.000 description 1
- ALRFTTOJSPMYSY-UHFFFAOYSA-N tin disulfide Chemical compound S=[Sn]=S ALRFTTOJSPMYSY-UHFFFAOYSA-N 0.000 description 1
- DZXKSFDSPBRJPS-UHFFFAOYSA-N tin(2+);sulfide Chemical compound [S-2].[Sn+2] DZXKSFDSPBRJPS-UHFFFAOYSA-N 0.000 description 1
- 229910000375 tin(II) sulfate Inorganic materials 0.000 description 1
- LTSUHJWLSNQKIP-UHFFFAOYSA-J tin(iv) bromide Chemical compound Br[Sn](Br)(Br)Br LTSUHJWLSNQKIP-UHFFFAOYSA-J 0.000 description 1
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 230000036347 tooth sensitivity Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 229910021655 trace metal ion Inorganic materials 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- VVGOCOMZRGWHPI-UHFFFAOYSA-N trans-hept-4-enal Natural products CCC=CCCC=O VVGOCOMZRGWHPI-UHFFFAOYSA-N 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- DXNCZXXFRKPEPY-UHFFFAOYSA-N tridecanedioic acid Chemical compound OC(=O)CCCCCCCCCCCC(O)=O DXNCZXXFRKPEPY-UHFFFAOYSA-N 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-I triphosphate(5-) Chemical compound [O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O UNXRWKVEANCORM-UHFFFAOYSA-I 0.000 description 1
- 229960004799 tryptophan Drugs 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- ABDKAPXRBAPSQN-UHFFFAOYSA-N veratrole Chemical compound COC1=CC=CC=C1OC ABDKAPXRBAPSQN-UHFFFAOYSA-N 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000003021 water soluble solvent Substances 0.000 description 1
- 239000009637 wintergreen oil Substances 0.000 description 1
- 239000010456 wollastonite Substances 0.000 description 1
- 229910052882 wollastonite Inorganic materials 0.000 description 1
- 239000004246 zinc acetate Substances 0.000 description 1
- 239000011667 zinc carbonate Substances 0.000 description 1
- 235000004416 zinc carbonate Nutrition 0.000 description 1
- 229910000010 zinc carbonate Inorganic materials 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
- VUDJAFZYSMINQA-UHFFFAOYSA-L zinc metaphosphate Chemical compound [Zn+2].[O-]P(=O)=O.[O-]P(=O)=O VUDJAFZYSMINQA-UHFFFAOYSA-L 0.000 description 1
- OMSYGYSPFZQFFP-UHFFFAOYSA-J zinc pyrophosphate Chemical compound [Zn+2].[Zn+2].[O-]P([O-])(=O)OP([O-])([O-])=O OMSYGYSPFZQFFP-UHFFFAOYSA-J 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- VRGNUPCISFMPEM-ZVGUSBNCSA-L zinc;(2r,3r)-2,3-dihydroxybutanedioate Chemical compound [Zn+2].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O VRGNUPCISFMPEM-ZVGUSBNCSA-L 0.000 description 1
- ZPEJZWGMHAKWNL-UHFFFAOYSA-L zinc;oxalate Chemical compound [Zn+2].[O-]C(=O)C([O-])=O ZPEJZWGMHAKWNL-UHFFFAOYSA-L 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/062—Oil-in-water emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
- A61K8/21—Fluorides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/22—Peroxides; Oxygen; Ozone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/26—Aluminium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/463—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
過酸化物及び水を含む、水和性口腔ケア組成物。過酸化物及び水を含む、水和性歯磨剤組成物。120秒以内に少なくとも約1%の過酸化物を放出することができる、過酸化物及び水を含む水和性口腔ケア組成物。15分以内に少なくとも約15%の過酸化物を放出することができる、過酸化物及び水を含む水和性口腔ケア組成物。A hydrating oral care composition comprising peroxide and water. A hydrating dentifrice composition comprising peroxide and water. A hydrating oral care composition comprising peroxide and water that is capable of releasing at least about 1% peroxide within 120 seconds. A hydrating oral care composition comprising peroxide and water that is capable of releasing at least about 15% peroxide within 15 minutes.
Description
本発明は、過酸化物及び水を含む、水和性口腔ケア組成物に関する。本発明は、過酸化物及び水を含む、水和性歯磨剤組成物に関する。 The present invention relates to hydratable oral care compositions comprising peroxide and water. The present invention relates to hydratable dentifrice compositions comprising peroxide and water.
歯磨剤組成物などの口腔ケア組成物は、歯を洗浄し、虫歯を予防し、歯及び歯肉などの口腔の審美性及び健康を維持するために、フッ化物、過酸化物、及び/又は研磨剤を含むことがある。 Oral care compositions, such as dentifrice compositions, contain fluoride, peroxide, and/or abrasives to clean teeth, prevent cavities, and maintain the aesthetics and health of the oral cavity, including teeth and gums. May contain agents.
高いホワイトニング効果を達成するために、比較的高濃度、例えば少なくとも約1%、少なくとも約3%、又は少なくとも約3.5%の過酸化物を含む歯磨剤組成物を有することが望ましい場合がある。しかしながら、過酸化物は、フッ化物、金属イオン、研磨剤などの他の歯磨剤成分と反応し得るため、比較的高濃度の過酸化物を含む歯磨剤組成物を配合することは困難であり得る。過酸化物に関連する配合課題に対する1つのアプローチは、別個に包装する、及び/又は別個のホワイトニング組成物から過酸化物を適用することであってもよい。しかしながら、過酸化物を別個の組成物から適用する必要がある場合、消費者のコンプライアンスはより低下し得る。したがって、過酸化物を、フッ化物などの他の成分と共に歯磨剤組成物中で提供することが有利であり得る。 To achieve high whitening effectiveness, it may be desirable to have dentifrice compositions that include relatively high concentrations of peroxide, such as at least about 1%, at least about 3%, or at least about 3.5%. . However, it is difficult to formulate dentifrice compositions containing relatively high concentrations of peroxide because peroxide can react with other dentifrice ingredients such as fluoride, metal ions, and abrasives. obtain. One approach to the formulation challenges associated with peroxide may be to package the peroxide separately and/or apply the peroxide from a separate whitening composition. However, consumer compliance may be lower if the peroxide needs to be applied from a separate composition. Therefore, it may be advantageous to provide peroxide in dentifrice compositions with other ingredients such as fluoride.
過酸化物に関連する配合課題に対する別のアプローチは、非水性シャーシ中の付加物及び/又は複合体として過酸化物を配合することであり得る。しかしながら、無水組成物は、過敏症、例えば歯の過敏症に寄与し得る口腔ケア表面の脱水をもたらし得る。更に、過酸化物の複合体化は、健康及び美容上の利益を提供するために利用可能な過酸化物の量をより低下させ得る。したがって、改善された水和性口腔ケア組成物、例えば、非複合体化過酸化物を含む改善された水和性歯磨剤組成物が必要とされている。 Another approach to the formulation challenges associated with peroxides may be to formulate the peroxides as adducts and/or complexes in a non-aqueous chassis. However, anhydrous compositions can lead to dehydration of oral care surfaces that can contribute to sensitivities, such as tooth sensitivity. Additionally, peroxide complexation may lower the amount of peroxide available to provide health and cosmetic benefits. Accordingly, there is a need for improved hydrating oral care compositions, such as improved hydrating dentifrice compositions containing uncomplexed peroxide.
本明細書に開示されるのは、(a)口腔ケア組成物の約1重量%~約5重量%の過酸化物と、(b)水と、を含む、口腔ケア組成物であり、口腔ケア組成物は、過酸化物放出法に従って、約120秒以内に少なくとも約1%の過酸化物を放出する。 Disclosed herein is an oral care composition comprising: (a) about 1% to about 5% peroxide, by weight of the oral care composition; and (b) water; The care composition releases at least about 1% peroxide within about 120 seconds according to a peroxide release method.
本明細書に開示されるのは、(a)口腔ケア組成物の約1重量%~約5重量%の過酸化物と、(b)水と、を含む、水和性口腔ケア組成物であり、口腔ケア組成物は、口腔への最初の適用から約120秒以内に、少なくとも約1%の過酸化物を使用者の口腔内に放出する。 Disclosed herein are hydratable oral care compositions comprising (a) about 1% to about 5% peroxide, by weight of the oral care composition; and (b) water. The oral care composition releases at least about 1% peroxide into the user's oral cavity within about 120 seconds of initial application to the oral cavity.
本明細書に開示されるのは、(a)口腔ケア組成物の約1重量%~約5重量%の過酸化物と、(b)水と、を含む、口腔ケア組成物であり、口腔ケア組成物は、過酸化物放出法に従って最小の適用から約15分以内に、少なくとも約15%の過酸化物を放出する。 Disclosed herein is an oral care composition comprising: (a) about 1% to about 5% peroxide, by weight of the oral care composition; and (b) water; The care composition releases at least about 15% peroxide within about 15 minutes of minimal application according to a peroxide release method.
本明細書に開示されるのは、(a)口腔ケア組成物の約1重量%~約5重量%の過酸化物と、(b)水と、を含む、水和性口腔ケア組成物であり、口腔ケア組成物は、口腔への最初の適用から約15分以内に、少なくとも約15%の過酸化物を使用者の口腔内に放出する。 Disclosed herein are hydratable oral care compositions comprising (a) about 1% to about 5% peroxide, by weight of the oral care composition; and (b) water. The oral care composition releases at least about 15% peroxide into the user's oral cavity within about 15 minutes of initial application to the oral cavity.
本明細書で開示されるのは、(a)疎水性相と、(b)水相と、(c)過酸化物と、を含む、密集水中油型エマルションであり、密集水中油型エマルションは、過酸化物放出法に従って約120秒以内に、少なくとも約1%の過酸化物を放出する。 Disclosed herein is a dense oil-in-water emulsion comprising (a) a hydrophobic phase, (b) an aqueous phase, and (c) a peroxide, wherein the dense oil-in-water emulsion is , releases at least about 1% peroxide within about 120 seconds according to a peroxide release method.
本明細書で開示されるのは、(a)疎水性相と、(b)水相と、(c)過酸化物と、を含む、密集水中油型エマルションであり、密集水中油型エマルションは、口腔への最初の適用から約120秒以内に、少なくとも約1%の過酸化物を使用者の口腔内に放出する。 Disclosed herein is a dense oil-in-water emulsion comprising (a) a hydrophobic phase, (b) an aqueous phase, and (c) a peroxide, wherein the dense oil-in-water emulsion is , releases at least about 1% peroxide into the user's oral cavity within about 120 seconds of initial application to the oral cavity.
本明細書で開示されるのは、(a)過酸化物と、(b)口腔ケア組成物の少なくとも約5重量%の水と、(c)フッ化物及び/又は研磨剤と、を含む、口腔ケア組成物である。 Disclosed herein are: (a) a peroxide; (b) at least about 5% water by weight of the oral care composition; (c) a fluoride and/or abrasive; An oral care composition.
本明細書で開示されるのは、使用者の口腔に過酸化物を送達する方法であって、(a)使用者に、開示される口腔ケア組成物のいずれかを口腔に適用するように指示することと、(b)使用者に、口腔ケア組成物の口腔への適用を少なくとも120秒間継続するように指示することと、を含む、方法である。 Disclosed herein is a method of delivering peroxide to the oral cavity of a user, the method comprising: (a) directing the user to apply any of the disclosed oral care compositions to the oral cavity; (b) instructing a user to continue applying the oral care composition to the oral cavity for at least 120 seconds.
本明細書では、シンクの代わりに使用者の口腔に過酸化物の大部分を送達する方法であって、(a)使用者に、開示される口腔ケア組成物のいずれかを口腔に適用するように指示することと、(b)使用者に、口腔ケア組成物の口腔への適用を少なくとも120秒間継続するように指示することと、(c)使用者に、口腔ケア組成物を吐き出すように指示することと、を含む、方法である。 Described herein is a method of delivering a majority of peroxide to a user's oral cavity instead of a sink, the method comprising: (a) having the user apply any of the disclosed oral care compositions to the oral cavity; (b) instructing the user to continue applying the oral care composition to the oral cavity for at least 120 seconds; and (c) instructing the user to spit out the oral care composition. A method comprising: instructing a person to:
本発明は、過酸化物及び水を含む、水和性口腔ケア組成物を目的とする。理論に束縛されるものではないが、錯化によって安定化され、無水シャーシ内に配置される過酸化物は、健康及び美容上の利益を提供するために利用可能な過酸化物の量をより少なくし得ると考えられる。加えて、無水組成物は脱水させる可能性があり、更なる感受性の課題をもたらす。 The present invention is directed to hydratable oral care compositions comprising peroxide and water. Without wishing to be bound by theory, it is believed that peroxide stabilized by complexation and placed within an anhydrous chassis increases the amount of peroxide available to provide health and cosmetic benefits. It is thought that it can be reduced. Additionally, anhydrous compositions can be dehydrating, presenting additional sensitivity challenges.
驚くべきことに、水を含む組成物中の過酸化物は、高い過酸化物放出率を有し、口腔に水分を与え得ることが見出された。理論に束縛されるものではないが、研磨剤を含む口腔ケア組成物中の残りの成分との反応性を最小限に抑えることによって、過酸化物を水を含む組成物中に配合できると考えられる。 Surprisingly, it has been found that peroxide in compositions containing water has a high peroxide release rate and can moisturize the oral cavity. Without wishing to be bound by theory, it is believed that peroxides can be incorporated into compositions containing water by minimizing reactivity with the remaining ingredients in oral care compositions containing abrasives. It will be done.
定義
本明細書で使用される用語をより明確に定義するために、以下の定義が提供される。別途記載のない限り、以下の定義は、本開示に適用可能である。ある用語が本開示で使用されているが本明細書で具体的に定義されていない場合、その定義が、本明細書に適用される任意の他の開示又は定義と矛盾しない限り、又はその定義が適用される任意の請求項を不明確に又は不可能にしない限り、IUPAC Compendium of Chemical Terminology,2nd Ed(1997)からの定義を適用することができる。
DEFINITIONS To more clearly define the terms used herein, the following definitions are provided. Unless otherwise stated, the following definitions are applicable to this disclosure. When a term is used in this disclosure but is not specifically defined herein, the definition does not conflict with any other disclosure or definition that applies to this specification; Definitions from the IUPAC Compendium of Chemical Terminology, 2nd Ed (1997) may be applied unless they obscure or render impossible any claims to which they apply.
用語「口腔ケア組成物」は、本明細書で使用する場合、通常の使用過程において、特定の治療剤を全身投与する目的で意図的に嚥下されるものではなく、むしろ、歯の表面又は口腔組織と接触させるのに十分な時間にわたって口腔内に保持される製品を包含する。口腔ケア組成物の例としては、歯磨剤、歯磨ゲル、歯肉縁下用ゲル、マウスリンス、ムース、フォーム、マウススプレー、トローチ剤、チュアブル錠、チューインガム、歯用ホワイトニングストリップ、フロス及びフロスコーティング、口臭予防用溶解ストリップ、又は義歯用ケア若しくは付着性製品が挙げられる。口腔ケア組成物はまた、口腔表面に直接塗布又は装着するためにストリップ又はフィルム上に組み込まれてもよい。 The term "oral care composition," as used herein, refers to a composition that, in the normal course of use, is not intended to be swallowed for the purpose of systemic administration of a particular therapeutic agent, but rather to the surface of the teeth or the oral cavity. Includes products that are retained in the oral cavity for a sufficient period of time to contact tissue. Examples of oral care compositions include dentifrices, tooth gels, subgingival gels, mouth rinses, mousses, foams, mouth sprays, lozenges, chewable tablets, chewing gum, tooth whitening strips, floss and floss coatings, bad breath. Includes prophylactic dissolving strips, or denture care or adhesive products. Oral care compositions may also be incorporated into strips or films for application or attachment directly to oral surfaces.
本明細書で使用する場合、用語「歯磨剤組成物」は、特に指示がない限り、歯用又は歯肉縁下用ペースト、ゲル、又は液体製剤を包含する。歯磨剤組成物は、単相組成物であってもよい、又は2つ以上の別個の歯磨剤組成物の組み合わせであってもよい。歯磨剤組成物は、深い縞状、表面的な縞状、多層状、ペーストをゲルで包囲した状態、又はそれらのいずれかの組み合わせなど、任意の所望の形態であってもよい。2つ以上の別個の歯磨剤組成物を含む歯磨剤中の各歯磨剤組成物は、ディスペンサの物理的に分離された区画内に収容され、同時に分注されてもよい。 As used herein, the term "dentifrice composition" includes dental or subgingival paste, gel, or liquid formulations, unless otherwise indicated. The dentifrice composition may be a single phase composition or a combination of two or more separate dentifrice compositions. The dentifrice composition may be in any desired form, such as deep stripes, superficial stripes, multilayers, paste surrounded by gel, or any combination thereof. Each dentifrice composition in a dentifrice containing two or more separate dentifrice compositions may be contained within physically separate compartments of the dispenser and dispensed simultaneously.
本明細書で有用な「有効物質及び他の成分」は、美容的及び/若しくは治療的効果、又はそれらが要求される作用形態若しくは機能により、本明細書において分類又は記載されてよい。しかしながら、本明細書において有用な有効物質及び他の成分は、場合によっては、2つ以上の美容的及び/又は治療的効果をもたらす、あるいは2つ以上の作用形態で機能又は作用してもよいと理解すべきである。したがって、本明細書における分類は便宜上実施されるものであり、成分を、列挙される具体的に規定した機能又は作用に制限しようとするものではない。 "Active substances and other ingredients" useful herein may be classified or described herein by their cosmetic and/or therapeutic effects, or their desired mode of action or function. However, the active substances and other ingredients useful herein may in some cases provide more than one cosmetic and/or therapeutic benefit or function or act in more than one mode of action. It should be understood that Accordingly, the classification herein is implemented for convenience and is not intended to limit the components to the specifically defined functions or actions listed.
用語「経口的に許容し得る担体」とは、局所口腔投与に好適な1種以上の相溶性のある固体若しくは液体賦形剤、又は希釈剤を含む。用語「相溶性」は、本明細書で使用する場合、組成物の構成成分が、組成物の安定性及び/又は有効性を実質的に低下させるような方式で相互作用することなく、混合されることができることを意味する。本発明のキャリア又は賦形剤は、以下により完全に記載されるように、マウスウォッシュ又はマウスリンスの通常の及び従来の構成成分を含むことができる。マウスウォッシュ又はマウスリンスのキャリア材料は、典型的には、これらに限定されるものではないが、水、アルコール、保湿剤、界面活性剤、及び、着香剤、甘味剤、着色剤及び/又は冷感剤などの許容改善剤のうちの1つ以上を含む。 The term "orally acceptable carrier" includes one or more compatible solid or liquid excipients or diluents suitable for topical oral administration. The term "compatible" as used herein means that the components of a composition are mixed without interacting in a manner that substantially reduces the stability and/or effectiveness of the composition. It means that you can. The carrier or excipient of the present invention can include the usual and conventional components of mouthwashes or mouthrinses, as described more fully below. Carrier materials for mouthwashes or mouthrinses typically include, but are not limited to, water, alcohol, humectants, surfactants, and flavoring, sweetening, coloring, and/or Contains one or more of the following tolerability modifiers, such as cooling sensation agents.
本明細書で使用する場合、用語「~を実質的に含まない」は、組成物中に、かかる組成物の総重量の0.05%以下、好ましくは0.01%以下、より好ましくは0.001%以下の指示物質が存在することを指す。 As used herein, the term "substantially free of" means that a composition contains no more than 0.05%, preferably no more than 0.01%, more preferably no more than 0.01% of the total weight of such composition. Refers to the presence of .001% or less of the indicator.
本明細書で使用する場合、用語「~を本質的に含まない」は、指示物質が組成物に意図的に添加されたものでないこと、又は好ましくは分析によって検出可能な濃度では存在しないことを意味する。これは、指示物質が、意図的に添加されたその他の物質のうちのいずれかの不純物としてのみ存在する、組成物を包含することを意味する。 As used herein, the term "essentially free of" means that the indicator has not been intentionally added to the composition or is preferably not present in an analytically detectable concentration. means. This is meant to encompass compositions in which the indicator is present only as an impurity among other intentionally added substances.
用語「口腔衛生レジメン」又は「レジメン」とは、口腔健康のための2つ以上に分かれた異なる処置工程、例えば、練り歯磨き、マウスリンス、フロス、爪楊枝、スプレー、口腔洗浄器、マッサージ器を使用するための用語であり得る。 The term "oral hygiene regimen" or "regimen" refers to two or more distinct treatment steps for oral health, such as using toothpaste, mouthrinse, floss, toothpicks, sprays, mouth irrigators, and massagers. It can be a term for
本明細書で使用するとき、用語「総含水量」とは、遊離水、及び口腔ケア組成物中の他の成分によって結合される水、の両方を意味する。 As used herein, the term "total water content" refers to both free water and water bound by other ingredients in the oral care composition.
本発明の目的のために、使用されるべき妥当な分子量(MW)は、組成物を調製する際に添加される材料の分子量であり、例えば、キレート剤がクエン酸、クエン酸ナトリウム又は実際に他の塩形態として供給され得るクエン酸化学種である場合、使用されるMWは、組成物に添加される特定の塩又は酸の分子量であるが、存在しうるいかなる結晶水をも無視した分子量である。 For the purposes of this invention, a reasonable molecular weight (MW) to be used is that of the material added when preparing the composition, for example if the chelating agent is citric acid, sodium citrate or For citric acid species that may be supplied as other salt forms, the MW used is the molecular weight of the particular salt or acid added to the composition, ignoring any water of crystallization that may be present. It is.
組成物及び方法は、本明細書において、様々な構成要素又は工程を「含む」という観点で記載されているが、組成物及び方法はまた、別途記載のない限り、様々な構成要素又は工程「から本質的になる」又は「からなる」こともできる。 Although compositions and methods are described herein in terms of "comprising" various components or steps, the compositions and methods also include "comprising" various components or steps, unless otherwise specified. It can also be "consisting essentially of" or "consisting essentially of."
本明細書で使用する場合、単語「又は」は、2つ以上の要素の接続詞として使用される場合に、要素を個々に、及び組み合わせで含むことを意味し、例えば、X又はYは、X若しくはY又はこれら両方を意味する。 As used herein, the word "or" when used as a conjunction of two or more elements is meant to include the elements individually and in combination, e.g. or Y or both.
本明細書で使用する場合、冠詞「a」及び「an」は、特許請求される又は記載される材料、例えば、「口腔ケア組成物」又は「漂白剤」の1つ以上を意味するものと理解される。 As used herein, the articles "a" and "an" shall refer to one or more of the claimed or described materials, e.g., "oral care composition" or "bleaching agent." be understood.
特に明記しない限り、本明細書で言及される測定は全て約23℃(すなわち、室温)で行われる。 Unless otherwise specified, all measurements referred to herein are performed at approximately 23° C. (ie, room temperature).
一般に、元素の族は、Chemical and Engineering News,63(5),27,1985に掲載されている元素周期表のバージョンで示される番号付けスキームを使用して示される。いくつかの例では、族に割り当てられた共通の名称を使用して、元素の族を示すことができ、例えば、第1族元素のアルカリ金属、第2族元素のアルカリ土類金属などが挙げられる。 Generally, groups of elements are designated using the numbering scheme shown in the version of the Periodic Table of the Elements published in Chemical and Engineering News, 63(5), 27, 1985. In some instances, a common name assigned to the group may be used to indicate a family of elements, such as alkali metals for Group 1 elements, alkaline earth metals for Group 2 elements, etc. It will be done.
いくつかの種類の範囲が本発明に開示される。任意の種類の範囲が開示又は特許請求される場合、範囲の端点並びにその中に包含される任意の部分範囲及び任意の部分範囲の組み合わせを含む、そのような範囲が合理的に包含し得る可能な各数を個々に開示又は特許請求することを意図している。 Several types of ranges are disclosed in this invention. When a range of any kind is disclosed or claimed, all possibilities that such range could reasonably include include the endpoints of the range and any subranges and combinations of subranges subsumed therein. It is intended that each number individually disclosed or claimed.
歯磨剤組成物は、固体、液体、粉末、ペースト、又はこれらの組み合わせなどの任意の好適な形態であり得る。口腔ケア組成物は、歯磨剤、歯磨ゲル、歯肉縁下用ゲル、マウスリンス、ムース、泡、マウススプレー、トローチ剤、チュアブル錠、チューインガム、歯用ホワイトニングストリップ、フロス及びフロスコーティング、口臭予防用溶解ストリップ、又は義歯用ケア若しくは付着性製品であり得る。歯磨剤組成物の構成成分は、フィルム、ストリップ、泡、又は繊維ベースの歯磨剤組成物に組み込まれることができる。 The dentifrice composition can be in any suitable form, such as solid, liquid, powder, paste, or combinations thereof. Oral care compositions include dentifrices, tooth gels, subgingival gels, mouth rinses, mousses, foams, mouth sprays, lozenges, chewable tablets, chewing gum, tooth whitening strips, floss and floss coatings, and solutions for preventing bad breath. It can be a strip, or a denture care or adhesive product. The components of the dentifrice composition can be incorporated into a film, strip, foam, or fiber-based dentifrice composition.
本明細書に記載の口腔ケア組成物は、過酸化物と、ピロリン酸カルシウムなどの過酸化物相溶性研磨剤と、を含む。更に、口腔ケア組成物は、以下に記載されるように、他の任意の成分を含み得る。以下のセクションヘッダーは、あくまでも便宜上提供されるものである。場合によっては、1つの化合物が、1つ以上のセクション内に含まれ得る。例えば、フッ化第一スズは、スズ化合物及び/又はフッ化物化合物であり得る。 The oral care compositions described herein include a peroxide and a peroxide-compatible abrasive, such as calcium pyrophosphate. Additionally, the oral care compositions may include other optional ingredients, as described below. The following section headers are provided for convenience only. In some cases, one compound may be included within one or more sections. For example, stannous fluoride can be a tin compound and/or a fluoride compound.
過酸化物
口腔ケア組成物は過酸化物を含む。過酸化物は、可溶化過酸化物化合物及び/又は固体過酸化物源などの任意の好適な過酸化物源を含むことができる。好適な過酸化物としては、固体過酸化物、過酸化水素、過酸化尿素、過酸化カルシウム、過酸化ベンゾイル、過酸化ナトリウム、過酸化バリウム、無機過酸化物、ヒドロペルオキシド、有機過酸化物、ポリビニルピロリドン-過酸化物複合体、架橋ポリビニルピロリドン-過酸化物複合体、及び/又はこれらの組み合わせが挙げられる。
Peroxide The oral care composition includes peroxide. The peroxide can include any suitable peroxide source, such as a solubilized peroxide compound and/or a solid peroxide source. Suitable peroxides include solid peroxides, hydrogen peroxide, urea peroxide, calcium peroxide, benzoyl peroxide, sodium peroxide, barium peroxide, inorganic peroxides, hydroperoxides, organic peroxides, Examples include polyvinylpyrrolidone-peroxide complexes, crosslinked polyvinylpyrrolidone-peroxide complexes, and/or combinations thereof.
理論に束縛されるものではないが、架橋ポリビニルピロリドン-過酸化物などの安定化化合物との複合体形成によって安定化される過酸化物化合物は、口腔に適用されたときに、ホワイトニング効果などの口腔健康効果を提供する利用能が低いと考えられる。したがって、過酸化物は、水性過酸化水素などの可溶化過酸化物化合物を含み得る。 Without wishing to be bound by theory, peroxide compounds that are stabilized by complex formation with stabilizing compounds such as cross-linked polyvinylpyrrolidone-peroxides may exhibit effects such as whitening effects when applied to the oral cavity. It is believed that the availability to provide oral health benefits is low. Thus, peroxides may include solubilized peroxide compounds such as aqueous hydrogen peroxide.
加えて、口腔ケア組成物は、例えば口腔ケア組成物の他の成分の選択を通じて、口腔ケア組成物を最初に混合した後の規定された期間後に残留過酸化物の量を最大化するように設計され得る。好適な口腔ケア組成物としては、口腔ケア組成物を50℃で10日間保管し、口腔ケア組成物中に残存する少なくとも約75%、少なくとも約80%、少なくとも約85%、少なくとも約90%、約90%~約99%、又は約88%~約99%の過酸化水素を含む、口腔ケア組成物が挙げられる。他の好適な口腔ケア組成物としては、口腔ケア組成物を50℃で20日間保管し、口腔ケア組成物中に残存する少なくとも約75%、少なくとも約80%、少なくとも約85%、少なくとも約90%、少なくとも約95%、約90%~約99%、又は約88%~約99%の過酸化水素を含む、口腔ケア組成物が挙げられる。 In addition, the oral care composition is designed to maximize the amount of peroxide remaining after a defined period of time after initially mixing the oral care composition, for example, through the selection of other ingredients of the oral care composition. can be designed. Suitable oral care compositions include at least about 75%, at least about 80%, at least about 85%, at least about 90% remaining in the oral care composition when the oral care composition is stored at 50° C. for 10 days; Oral care compositions include about 90% to about 99%, or about 88% to about 99% hydrogen peroxide. Other suitable oral care compositions include at least about 75%, at least about 80%, at least about 85%, at least about 90% remaining in the oral care composition when the oral care composition is stored at 50°C for 20 days. %, at least about 95%, about 90% to about 99%, or about 88% to about 99% hydrogen peroxide.
口腔ケア組成物は、口腔ケア組成物の約0.01重量%~約20重量%、約0.01重量%~約10重量%、約1重量%~約5重量%、少なくとも約1重量%、少なくとも約2重量%、少なくとも約3重量%、少なくとも約3.5重量%、少なくとも約4重量%、又は3重量%超の過酸化物を含み得る。 The oral care composition comprises about 0.01% to about 20%, about 0.01% to about 10%, about 1% to about 5%, at least about 1%, by weight of the oral care composition. , at least about 2%, at least about 3%, at least about 3.5%, at least about 4%, or more than 3% by weight peroxide.
理論に束縛されるものではないが、本明細書に記載の過酸化物は、口腔ケア組成物中の他の成分によって、結合されていなくても、複合体を形成していなくても、及び/又は最小限にしか安定化されていなくてもよいと考えられる。更に、両親媒性ポリマー及び/又は他の増粘剤などの口腔ケア組成物中の他の成分に結合していない、複合体を形成していない、及び/又は最小限にしか安定化されていない過酸化物を含む口腔ケア組成物は、ポリビニルピロリドン-過酸化物などの過酸化物付加物、及び/又は他の結合過酸化物源を有する組成物よりも、高い過酸化物放出率をもたらし得ると考えられる。望ましい口腔ケア組成物としては、30秒、45秒、60秒、75秒、90秒、120秒、及び/又は5分などの1回の口腔ケア時間に対応する規定された時間において、少なくとも約10%、少なくとも約15%、少なくとも約25%、少なくとも約35%、少なくとも約50%、少なくとも約60%、少なくとも約70%、少なくとも約75%、少なくとも約80%、少なくとも約90%、少なくとも約95%、約10%~約95%、約25%~約75%、約20%~約95%、約35%~約90%、約40%~約95%、約50%~約90%、及び約60%~約99%の過酸化物放出を有する、口腔ケア組成物が挙げられる。 Without wishing to be bound by theory, the peroxides described herein may be present even if unbound or uncomplexed by other ingredients in the oral care composition; and/or may be minimally stabilized. Additionally, it is not bound, non-complexed, and/or only minimally stabilized to other ingredients in the oral care composition, such as amphiphilic polymers and/or other thickening agents. Oral care compositions containing no peroxide have higher peroxide release rates than compositions with peroxide adducts such as polyvinylpyrrolidone-peroxide and/or other sources of bound peroxide. It is thought that it can be brought about. Desirable oral care compositions include at least about 10%, at least about 15%, at least about 25%, at least about 35%, at least about 50%, at least about 60%, at least about 70%, at least about 75%, at least about 80%, at least about 90%, at least about 95%, about 10% to about 95%, about 25% to about 75%, about 20% to about 95%, about 35% to about 90%, about 40% to about 95%, about 50% to about 90% , and oral care compositions having a peroxide release of about 60% to about 99%.
研磨剤
口腔ケア組成物は、過酸化物相溶性研磨剤などの研磨剤を含み得る。研磨剤は、歯から表面の着色汚れを除去するのを助けるために口腔ケア製剤に添加され得る。研磨剤は、カルシウム研磨剤、シリカ研磨剤、カーボネート研磨剤、ホスフェート研磨剤、アルミナ研磨剤、他の好適な研磨剤、及び/又はこれらの組み合わせを含み得る。
Abrasives The oral care compositions may include abrasives, such as peroxide-compatible abrasives. Abrasives may be added to oral care formulations to help remove surface stains from teeth. The abrasive may include a calcium abrasive, a silica abrasive, a carbonate abrasive, a phosphate abrasive, an alumina abrasive, other suitable abrasives, and/or combinations thereof.
カルシウム研磨剤は、炭酸カルシウム、リン酸二カルシウム、リン酸三カルシウム、オルトリン酸カルシウム、メタリン酸カルシウム、ピロリン酸カルシウム、ポリリン酸カルシウム、カルシウムヒドロキシアパタイト、及びこれらの組み合わせを含み得る。 Calcium abrasives can include calcium carbonate, dicalcium phosphate, tricalcium phosphate, calcium orthophosphate, calcium metaphosphate, calcium pyrophosphate, calcium polyphosphate, calcium hydroxyapatite, and combinations thereof.
カルシウム研磨剤は、炭酸カルシウムを含み得る。カルシウム含有研磨剤は、微粉砕天然白亜、粉砕炭酸カルシウム、沈殿炭酸カルシウム、及びこれらの組み合わせからなる群から選択することができる。 Calcium abrasives may include calcium carbonate. The calcium-containing abrasive can be selected from the group consisting of finely ground natural chalk, ground calcium carbonate, precipitated calcium carbonate, and combinations thereof.
カルシウム研磨剤は、ピロリン酸カルシウムを含み得る。理論に束縛されるものではないが、ピロリン酸カルシウムの特定の供給源は、過酸化物を含む口腔ケア組成物において使用される過酸化物と十分に相溶性であり得ると考えられる。ピロリン酸カルシウムは、少なくとも3つの多形相、アルファ(α)、ベータ(β)、及びガンマ(γ)を有する。予期せぬことに、より高い割合のγ相を有するピロリン酸カルシウムは、過酸化水素などの過酸化物との相溶性がより高いことが見出された。ピロリン酸カルシウムの好適な供給源は、少なくとも約0.75、少なくとも約0.8、少なくとも約0.9、少なくとも約1、約0.75~約1.5、約0.9~約1.5、又は約1~約1.5の、γ相ピロリン酸カルシウムのβ相ピロリン酸カルシウムに対する比を含み得る。 Calcium abrasives may include calcium pyrophosphate. Without wishing to be bound by theory, it is believed that certain sources of calcium pyrophosphate may be sufficiently compatible with peroxides used in peroxide-containing oral care compositions. Calcium pyrophosphate has at least three polymorphic forms: alpha (α), beta (β), and gamma (γ). Unexpectedly, it has been found that calcium pyrophosphate with a higher proportion of gamma phase is more compatible with peroxides such as hydrogen peroxide. Suitable sources of calcium pyrophosphate include at least about 0.75, at least about 0.8, at least about 0.9, at least about 1, about 0.75 to about 1.5, about 0.9 to about 1.5 , or a ratio of gamma phase calcium pyrophosphate to beta phase calcium pyrophosphate from about 1 to about 1.5.
理論に束縛されるものではないが、多量の可溶性金属イオンを含む研磨剤は、過酸化物と金属イオンとの間の反応性のために、過酸化物との相溶性が低いと考えられる。したがって、ピロリン酸カルシウムなどの好適な研磨剤源は、研磨剤の約0.001重量%未満、約0.00075重量%未満、約0.0006重量%未満、約0.0005重量%未満、又は約0.0001重量%未満を構成することができる。更に、研磨剤は、可溶性金属イオンを含まない、実質的に含まない、又は本質的に含まないことが可能である。研磨剤中に存在する可能性があり、過酸化物分解を誘発することがこれまで報告されている微量金属イオンの例としては、Cr、Mn、Fe、Co、Ni、Cu、Mo、及び/又はこれらの組み合わせが挙げられる。 Without wishing to be bound by theory, it is believed that polishing agents containing large amounts of soluble metal ions are less compatible with peroxides due to the reactivity between the peroxides and metal ions. Accordingly, suitable abrasive sources, such as calcium pyrophosphate, provide less than about 0.001%, less than about 0.00075%, less than about 0.0006%, less than about 0.0005%, or about It can constitute less than 0.0001% by weight. Additionally, the abrasive can be free, substantially free, or essentially free of soluble metal ions. Examples of trace metal ions that may be present in abrasives and have been previously reported to induce peroxide decomposition include Cr, Mn, Fe, Co, Ni, Cu, Mo, and/or Or a combination thereof.
本明細書に記載されるように、予期せぬことに、約5.4~約7のスラリーpHを有する研磨剤が、過酸化物との相溶性がより高いことも見出された。スラリーpHは、1:3の研磨剤:水スラリーを作製し、pHを測定することによって決定した。 As described herein, it has also been unexpectedly found that abrasives having a slurry pH of about 5.4 to about 7 are more compatible with peroxide. Slurry pH was determined by making a 1:3 abrasive:water slurry and measuring the pH.
カーボネート研磨剤は、炭酸ナトリウム、重炭酸ナトリウム、炭酸カルシウム、炭酸ストロンチウム、及び/又はこれらの組み合わせを含むことができる。 Carbonate abrasives can include sodium carbonate, sodium bicarbonate, calcium carbonate, strontium carbonate, and/or combinations thereof.
ホスフェート研磨剤は、リン酸カルシウム、ヘキサメタリン酸ナトリウム、リン酸二カルシウム、リン酸三カルシウム、オルトリン酸カルシウム、メタリン酸カルシウム、ポリリン酸カルシウム、ポリホスフェート、ピロホスフェート、及び/又はこれらの組み合わせを含むことができる。 The phosphate abrasive can include calcium phosphate, sodium hexametaphosphate, dicalcium phosphate, tricalcium phosphate, calcium orthophosphate, calcium metaphosphate, calcium polyphosphate, polyphosphate, pyrophosphate, and/or combinations thereof.
シリカ研磨剤は、溶融シリカ、ヒュームドシリカ、沈降シリカ、水和シリカ、及び/又はこれらの組み合わせを含むことができる。 Silica abrasives can include fused silica, fumed silica, precipitated silica, hydrated silica, and/or combinations thereof.
アルミナ研磨剤は、多結晶アルミナ、焼成アルミナ、無焼成アルミナ、溶融アルミナ、湿式粉砕アルミナ、水和アルミナ、及び/又はこれらの組み合わせを含むことができる。 Alumina abrasives can include polycrystalline alumina, calcined alumina, uncalcined alumina, fused alumina, wet ground alumina, hydrated alumina, and/or combinations thereof.
他の好適な研磨剤としては、珪藻土、硫酸バリウム、ウォラストナイト、パーライト、ポリメチルメタクリレート粒子、トスパール、及びこれらの組み合わせが挙げられる。 Other suitable abrasives include diatomaceous earth, barium sulfate, wollastonite, perlite, polymethyl methacrylate particles, Tospearl, and combinations thereof.
口腔ケア組成物は、口腔ケア組成物の約0.01重量%~約30重量%、約0.01重量%~約15重量%、約0.01重量%~15重量%未満、約1重量%~約30重量%、約1重量%~15重量%未満、約1重量%~約12重量%、又は約0.01重量%~約10重量%の研磨剤を含み得る。 The oral care composition comprises about 0.01% to about 30%, about 0.01% to about 15%, about 0.01% to less than 15%, about 1% by weight of the oral care composition. % to about 30%, about 1% to less than 15%, about 1% to about 12%, or about 0.01% to about 10% by weight of the abrasive.
口腔ケア組成物は、少なくとも約75、少なくとも約90、少なくとも約100、約75~約250、又は約100~約250のペリクル洗浄比(PCR)を有し得る。 The oral care composition can have a pellicle cleansing ratio (PCR) of at least about 75, at least about 90, at least about 100, from about 75 to about 250, or from about 100 to about 250.
口腔ケア組成物は、最大約250、最大約150、約70~約150、又は約50~約250の相対的象牙質研磨効率を有し得る。 The oral care composition can have a relative dentin polishing efficiency of up to about 250, up to about 150, from about 70 to about 150, or from about 50 to about 250.
アルミナ
口腔ケア組成物は、研磨剤としてアルミナを含み得る。アルミナは、単独の研磨剤であってもよく、又は本明細書に記載されるような他の研磨剤と組み合わせて使用されてもよい。アルミナの研磨性はシリカよりも高くなり得るため、より少量のアルミナ研磨剤を添加することができる。
Alumina The oral care composition may include alumina as an abrasive. Alumina may be the sole abrasive or may be used in combination with other abrasives as described herein. Since the abrasiveness of alumina can be higher than silica, smaller amounts of alumina abrasive can be added.
アルミナを含む口腔ケア組成物は、少なくとも約15、少なくとも約20、少なくとも約25、又は少なくとも約40の硬組織安全値(REA)を有し得る。 Oral care compositions comprising alumina can have a hard tissue safety value (REA) of at least about 15, at least about 20, at least about 25, or at least about 40.
アルミナを含む口腔ケア組成物は、少なくとも約75、少なくとも約100、約75~約250、約50~約175、約50~約150、又は約65~約155のペリクル洗浄比(PCR)を有し得る。 Oral care compositions comprising alumina have a pellicle cleaning ratio (PCR) of at least about 75, at least about 100, about 75 to about 250, about 50 to about 175, about 50 to about 150, or about 65 to about 155. It is possible.
アルミナを含む口腔ケア組成物は、約150未満、約125未満、約100未満、又は約90未満の相対的象牙質研磨効率(RDA)を有し得る。 Oral care compositions that include alumina can have a relative dentin abrasion efficiency (RDA) of less than about 150, less than about 125, less than about 100, or less than about 90.
理論に束縛されるものではないが、アルミナは過酸化物及び/又はフッ化物と反応し得ると考えられる。したがって、望ましいアルミナ研磨剤としては、過酸化物及び/又はフッ化物と相溶性のあるものが挙げられる。好適な口腔ケア組成物としては、口腔ケア組成物を40℃で30及び/又は60日間保管し、口腔ケア組成物中に残存する少なくとも約75%、少なくとも約80%、少なくとも約85%、少なくとも約90%、少なくとも約95%、約90%~約99%、又は約88%~約99%の過酸化水素を含む、口腔ケア組成物が挙げられる。 Without wishing to be bound by theory, it is believed that alumina may react with peroxides and/or fluorides. Accordingly, desirable alumina abrasives include those that are compatible with peroxides and/or fluorides. Suitable oral care compositions include at least about 75%, at least about 80%, at least about 85%, at least about 85% remaining in the oral care composition when the oral care composition is stored at 40° C. for 30 and/or 60 days. Oral care compositions include about 90%, at least about 95%, about 90% to about 99%, or about 88% to about 99% hydrogen peroxide.
他の好適な口腔ケア組成物としては、過酸化物及びアルミナを含み、40℃で30日及び/又は90日後に、約10%未満、約5%未満、約4%未満、約3%未満、約0.5%~約10%、約0.5%~約5%、又は約0.1%~約5%の過酸化物損失%を有する口腔ケア組成物が挙げられる。理論に束縛されるものではないが、アルミナは、アルミナについて予想外に安定であり、過酸化物の分解及び/又は劣化に対して失われる過酸化物の量は最小限であると考えられる。 Other suitable oral care compositions include peroxide and alumina and after 30 and/or 90 days at 40° C. less than about 10%, less than about 5%, less than about 4%, less than about 3% , about 0.5% to about 10%, about 0.5% to about 5%, or about 0.1% to about 5%. Without wishing to be bound by theory, it is believed that alumina is unexpectedly stable for alumina, and the amount of peroxide lost to peroxide decomposition and/or degradation is minimal.
他の好適な口腔ケア組成物としては、過酸化物、フッ化物、及びアルミナを含み、40℃で30日及び/又は90日後に、約20%未満、約18%未満、約15%未満、約10%未満、約5%未満、約0.5%~約10%、約0.5%~約20%、又は約0.1%~約15%のフッ化物損失%を有する口腔ケア組成物が挙げられる。理論に束縛されるものではないが、アルミナ及び過酸化物は、特定のフッ化物源について予想外に安定であり、フッ化物の最小限の損失のみが観察されると考えられる。 Other suitable oral care compositions include peroxide, fluoride, and alumina, and after 30 and/or 90 days at 40° C. less than about 20%, less than about 18%, less than about 15%; Oral care compositions having a % fluoride loss of less than about 10%, less than about 5%, about 0.5% to about 10%, about 0.5% to about 20%, or about 0.1% to about 15%. Things can be mentioned. Without wishing to be bound by theory, it is believed that alumina and peroxide are unexpectedly stable with certain fluoride sources and only minimal loss of fluoride is observed.
他の好適な口腔ケア組成物としては、過酸化物及びアルミナを含み、40℃で30日及び/又は90日の、少なくとも約5%、少なくとも約10%、少なくとも約15%、少なくとも約20%、少なくとも約25%、少なくとも約35%、少なくとも約50%、少なくとも約75%、少なくとも約100%、約5%~約125%、約5%~約50%、又は約1%~約75%の粘度増加%を有する口腔ケア組成物が挙げられる。理論に束縛されるものではないが、アルミナと過酸化物との組み合わせは予想外に安定であり、これにより、過酸化物の分解に起因して通常観察される準安定過酸化物組成物における粘度の低下を最小限に抑え得ると考えられる。 Other suitable oral care compositions include peroxide and alumina, at least about 5%, at least about 10%, at least about 15%, at least about 20% for 30 days and/or 90 days at 40°C. , at least about 25%, at least about 35%, at least about 50%, at least about 75%, at least about 100%, about 5% to about 125%, about 5% to about 50%, or about 1% to about 75%. Oral care compositions having a % viscosity increase of . Without wishing to be bound by theory, it is believed that the combination of alumina and peroxide is unexpectedly stable, making it less likely that metastable peroxide compositions are commonly observed due to peroxide decomposition. It is believed that the decrease in viscosity can be minimized.
口腔ケア組成物は、口腔ケア組成物の約0.01重量%~約10重量%、約0.01重量%~約5重量%、約0.1重量%~約5重量%、約0.01重量%~約3重量%、又は約0.01重量%~約1重量%のアルミナを含み得る。 The oral care composition may contain about 0.01% to about 10%, about 0.01% to about 5%, about 0.1% to about 5%, about 0.01% to about 5%, about 0.1% to about 5%, by weight of the oral care composition. 0.01% to about 3%, or about 0.01% to about 1% by weight alumina.
水
本発明の口腔ケア組成物は、無水、低含水製剤、又は高含水製剤である歯磨剤組成物であり得る。合計で、口腔ケア組成物は、組成物の0重量%~約99重量%、約5重量%~約60重量%、約5重量%~約75重量%、約20重量%以上、約30重量%以上、約50重量%以上、最大約45重量%、又は最大約75重量%の水を含み得る。好ましくは、水は、USP水である。
Water The oral care compositions of the present invention can be dentifrice compositions that are anhydrous, low water content formulations, or high water content formulations. In total, the oral care composition comprises 0% to about 99%, about 5% to about 60%, about 5% to about 75%, about 20% or more, about 30% by weight of the composition. % or more, about 50% or more, up to about 45%, or up to about 75% by weight water. Preferably the water is USP water.
本発明の口腔ケア組成物は、水を含み得る。理論に束縛されるものではないが、口腔ケア組成物中に水を含むことは、口腔に水分を与える一方で、ホワイトニングなどの口腔健康効果を提供するための過酸化物のより高い利用可能性をもたらし得ると考えられる。過酸化物を安定化させる1つの選択肢は、無水歯磨剤組成物中に錯化過酸化物を提供することであるが、口腔ケア組成物の他の成分を選択することによって、同時に口腔に水分を与えながら、過酸化物をより効果的に送達できると考えられる。 Oral care compositions of the present invention may include water. Without wishing to be bound by theory, the inclusion of water in oral care compositions provides greater availability of peroxide to provide oral health benefits such as whitening while hydrating the oral cavity. It is thought that this can lead to One option for stabilizing peroxide is to provide complexed peroxide in the anhydrous dentifrice composition, while simultaneously adding moisture to the oral cavity by selecting other ingredients in the oral care composition. It is believed that peroxide can be delivered more effectively while providing
高含水歯磨剤製剤では、歯磨剤組成物は、組成物の約45重量%~約75重量%の水を含む。高含水歯磨剤組成物は、組成物の約45重量%~約65重量%、約45重量%~約55重量%、又は約46重量%~約54重量%の水を含んでもよい。水は、高含水歯磨剤製剤に直接添加されてもよい、及び/又は他の成分を含めることによって組成物に含まれてもよい。 In high water content dentifrice formulations, the dentifrice composition contains from about 45% to about 75% water by weight of the composition. Highly hydrated dentifrice compositions may include from about 45% to about 65%, from about 45% to about 55%, or from about 46% to about 54% water, by weight of the composition. Water may be added directly to the high water content dentifrice formulation and/or may be included in the composition by including other ingredients.
低含水歯磨剤製剤では、歯磨剤組成物は、組成物の約5重量%~約45重量%、又は約10重量%~約45重量%の水を含む。低含水歯磨剤組成物は、組成物の約10重量%~約35重量%、約15重量%~約25重量%、又は約20重量%~約25重量%の水を含んでもよい。水は、低含水歯磨剤製剤に直接添加されてもよい、及び/又は他の成分を含めることによって組成物に含まれてもよい。 In low water content dentifrice formulations, the dentifrice composition contains from about 5% to about 45% water, or from about 10% to about 45%, by weight of the composition. Low water content dentifrice compositions may contain from about 10% to about 35%, from about 15% to about 25%, or from about 20% to about 25% water, by weight of the composition. Water may be added directly to the low water content dentifrice formulation and/or may be included in the composition by including other ingredients.
無水歯磨剤製剤において、歯磨剤組成物は、組成物の約10重量%未満の水を含む。無水歯磨剤組成物は、組成物の約5重量%未満、約1重量%未満、又は0重量%の水を含む。水は、無水製剤に直接添加されてもよい、及び/又は他の成分を含めることによって歯磨剤組成物に含まれてもよい。 In anhydrous dentifrice formulations, the dentifrice composition contains less than about 10% water by weight of the composition. Anhydrous dentifrice compositions contain less than about 5%, less than about 1%, or 0% water by weight of the composition. Water may be added directly to the anhydrous formulation and/or may be included in the dentifrice composition by including other ingredients.
歯磨剤組成物はまた、アルコール、保湿剤、ポリマー、界面活性剤、並びに許容改善剤、例えば、着香剤、甘味剤、着色剤及び/又は冷感剤などの、他の口腔に許容可能なキャリア材料を含むことができる。 The dentifrice compositions also contain other orally acceptable agents such as alcohols, humectants, polymers, surfactants, and tolerability-improving agents, such as flavoring agents, sweetening agents, coloring agents, and/or cooling agents. A carrier material may be included.
口腔ケア組成物はまた、マウスリンス製剤であってもよい。マウスリンス製剤は、約75%~約99%、約75%~約95%、又は約80%~約95%の水を含み得る。 Oral care compositions may also be mouthrinse formulations. Mouth rinse formulations may contain about 75% to about 99%, about 75% to about 95%, or about 80% to about 95% water.
両親媒性ポリマー
口腔ケア組成物は、両親媒性ポリマーを含み得る。両親媒性ポリマーは、過酸化物相溶性増粘剤として含まれ得る。両親媒性ポリマーは、疎水性部分及び親水性部分を有するポリマーを含み得る。例えば、ポリマーは、親水性骨格及び疎水性サブユニットを含む高分子を含み得る。これは、両親媒性ポリマーが、過酸化物との強い相互作用を防止しながら、水に可溶性のままであることを可能にし得る。
Amphiphilic Polymers Oral care compositions can include amphiphilic polymers. Amphiphilic polymers may be included as peroxide compatible thickeners. Amphiphilic polymers can include polymers that have hydrophobic portions and hydrophilic portions. For example, a polymer can include a macromolecule that includes a hydrophilic backbone and hydrophobic subunits. This may allow the amphiphilic polymer to remain soluble in water while preventing strong interactions with peroxides.
本明細書に記載されるように、他の成分が過酸化物との反応性を最小限にするように設計される場合、過酸化物は水性シャーシ中に効果的に送達され得ると考えられる。したがって、両親媒性ポリマーが過酸化物と強く反応しないことが望ましい。したがって、両親媒性ポリマーが過酸化物と単離可能な複合体を形成しないことが望ましい。 It is believed that peroxide can be effectively delivered into the aqueous chassis if the other components are designed to minimize reactivity with the peroxide, as described herein. . Therefore, it is desirable that amphiphilic polymers do not react strongly with peroxides. Therefore, it is desirable that the amphiphilic polymer not form an isolable complex with the peroxide.
両親媒性ポリマーは、水に少なくとも部分的に可溶性及び/又は完全に可溶性であるポリマーを含み得る。 Amphiphilic polymers may include polymers that are at least partially and/or completely soluble in water.
好適な両親媒性ポリマーとしては、2-アクリルアミド-2-メチルプロパンスルホン酸(AMPS)ポリマー、コポリマー、クロスポリマー、又はこれらの組み合わせが挙げられる。一例では、口腔ケア組成物は、ポリアクリレートクロスポリマー-6(Air Liquideグループ(Puteaux Cedex,France)の子会社であるSEPPIC S.A.からSepIMax(商標)ZENとして市販されている)を含有し得る。 Suitable amphiphilic polymers include 2-acrylamido-2-methylpropanesulfonic acid (AMPS) polymers, copolymers, crosspolymers, or combinations thereof. In one example, the oral care composition may contain polyacrylate crosspolymer-6 (commercially available as SepIMax™ ZEN from SEPPIC S.A., a subsidiary of Air Liquide Group, Puteaux Cedex, France). .
口腔ケア組成物は、口腔ケア組成物の約0.01重量%~約10重量%、約0.1重量%~約5重量%、約1重量%~約10重量%、又は約1重量%~約5重量%の両親媒性ポリマーを含み得る。 The oral care composition comprises about 0.01% to about 10%, about 0.1% to about 5%, about 1% to about 10%, or about 1% by weight of the oral care composition. It may contain up to about 5% by weight of amphiphilic polymer.
アルキルアルコール
口腔ケア組成物は、アルキルアルコールを含み得る。理論に束縛されるものではないが、両親媒性ポリマーと組み合わせたアルキルアルコールの添加は、予想外に高い粘度を有する口腔ケア組成物をもたらすことができると考えられる。
Alkyl Alcohols Oral care compositions may include alkyl alcohols. Without wishing to be bound by theory, it is believed that the addition of an alkyl alcohol in combination with an amphiphilic polymer can result in an oral care composition having an unexpectedly high viscosity.
アルキルアルコールは、アルキル官能基及びアルコール官能基を有する化合物を含み得る。アルキル官能基は、直鎖、分岐鎖、環状、又はそれらの組み合わせであり得る。アルキルアルコールは、第一級アルコール、第二級アルコール、及び/又は第三級アルコールを含み得る。 Alkyl alcohols can include compounds having an alkyl functional group and an alcohol functional group. The alkyl functionality can be straight chain, branched, cyclic, or a combination thereof. Alkyl alcohols can include primary alcohols, secondary alcohols, and/or tertiary alcohols.
アルキルアルコールは、CnH2n+1OHの一般式によって表すことができ、式中、nは、1~30、10~20、又は10~25の任意の整数であり得る。 Alkyl alcohols can be represented by the general formula C n H 2n+1 OH, where n can be any integer from 1 to 30, 10 to 20, or 10 to 25.
アルキルアルコールの具体例としては、1-ヘプタコサノール、1-ヘキサコサノール、1-ノナコサノール、1-オクタコサノール、1-テトラコサノール、ドコサノール、ヘンエイコサン-1-オール、ペンタコサン-1-オール、トリコサン-1-オール、1,4-ブタンジオール、1-ヘプタノール、1-ヘキサノール、1-ノナノール、1-オクタノール、1-ペンタノール、1-プロパノール、2,4-ジクロロベンジルアルコール、2-エチルヘキサノール、3-ニトロベンジルアルコール、アリルアルコール、アニシルアルコール、アラキジルアルコール、ベンジルアルコール、セチルアルコール、シンナミルアルコール、クロチルアルコール、フルフリルアルコール、イソアミルアルコール、ネオペンチルアルコール、ニコチニルアルコール、ペリリルアルコール、フェネチルアルコール、プロパルギルアルコール、サリチルアルコール、ステアリルアルコール、トリプトホール、バニリルアルコール、ベラトロールアルコール、及び/又はこれらの組み合わせを挙げることができる。アルキルアルコールは、ステアリルアルコール、セチルアルコール、及び/又はこれらの組み合わせを含み得る。 Specific examples of alkyl alcohols include 1-heptacosanol, 1-hexacosanol, 1-nonacosanol, 1-octacosanol, 1-tetracosanol, docosanol, heneicosan-1-ol, pentacosan-1-ol, and tricosan-1-ol. alcohol, 1,4-butanediol, 1-heptanol, 1-hexanol, 1-nonanol, 1-octanol, 1-pentanol, 1-propanol, 2,4-dichlorobenzyl alcohol, 2-ethylhexanol, 3-nitro Benzyl alcohol, allyl alcohol, anisyl alcohol, arachidyl alcohol, benzyl alcohol, cetyl alcohol, cinnamyl alcohol, crotyl alcohol, furfuryl alcohol, isoamyl alcohol, neopentyl alcohol, nicotinyl alcohol, perillyl alcohol, phenethyl alcohol, Mention may be made of propargyl alcohol, salicyl alcohol, stearyl alcohol, tryptophol, vanillyl alcohol, veratrol alcohol, and/or combinations thereof. Alkyl alcohols may include stearyl alcohol, cetyl alcohol, and/or combinations thereof.
アルキルアルコールは、45:45:10の比のセチルアルコール:ステアリルアルコール:ラウリル硫酸ナトリウムを含むLanette(登録商標)W(BASF(Florham Park,NJ)から入手可能)などの、アルキルアルコールの市販の混合物によって提供することができる。 The alkyl alcohol can be a commercially available mixture of alkyl alcohols, such as Lanette® W (available from BASF, Florham Park, NJ), which contains a 45:45:10 ratio of cetyl alcohol:stearyl alcohol:sodium lauryl sulfate. can be provided by.
口腔ケア組成物は、口腔ケア組成物の約0.01重量%~約10重量%、約0.1重量%~約5重量%、約1重量%~約10重量%、又は約1重量%~約5重量%のアルキルアルコールを含み得る。 The oral care composition comprises about 0.01% to about 10%, about 0.1% to about 5%, about 1% to about 10%, or about 1% by weight of the oral care composition. It may contain up to about 5% by weight alkyl alcohol.
両親媒性ポリマーとアルキルアルコールの組み合わせは、予想外に高い粘度を有する口腔ケア組成物をもたらすことができる。両親媒性ポリマー:アルキルアルコールの好適な比は、少なくとも約0.25、少なくとも約0.5、少なくとも約0.75、少なくとも約1、約0.25~約5、約0.5~1.5、又は約1であり得る。 The combination of amphiphilic polymers and alkyl alcohols can result in oral care compositions with unexpectedly high viscosities. Suitable amphiphilic polymer:alkyl alcohol ratios are at least about 0.25, at least about 0.5, at least about 0.75, at least about 1, about 0.25 to about 5, about 0.5 to 1. 5, or about 1.
口腔ケア組成物は、少なくとも約5cP、少なくとも約10cP、少なくとも約20cP、約5cP~約20cP、又は約1cP~約25cPの粘度を有し得る。 The oral care composition can have a viscosity of at least about 5 cP, at least about 10 cP, at least about 20 cP, about 5 cP to about 20 cP, or about 1 cP to about 25 cP.
pH
開示される組成物のpHは、約4~約10、約4~約7、約4~約8、又は約7~約10であり得る。
pH
The pH of the disclosed compositions can be from about 4 to about 10, from about 4 to about 7, from about 4 to about 8, or from about 7 to about 10.
フッ化物
口腔ケア組成物は、フッ化物を含み得、そのフッ化物は、フッ化物イオン源によって提供され得る。フッ化物イオン源は、フッ化第一スズ、フッ化ナトリウム、フッ化カリウム、フッ化アミン、モノフルオロリン酸ナトリウム、フッ化亜鉛、及び/又はこれらの混合物などの1つ以上のフッ化物イオン含有化合物を含むことができる。
Fluoride The oral care composition may include fluoride, which may be provided by a fluoride ion source. The fluoride ion source contains one or more fluoride ions, such as stannous fluoride, sodium fluoride, potassium fluoride, fluorinated amines, sodium monofluorophosphate, zinc fluoride, and/or mixtures thereof. Compounds can be included.
フッ化物イオン源及びスズイオン源は、スズイオン及びフッ化物イオンを生成することができる、例えば、フッ化第一スズなどの同じ化合物であり得る。加えて、フッ化物イオン源及びスズイオン源は、スズイオン源が塩化第一スズであり、フッ化物イオン源がモノフルオロリン酸ナトリウム又はフッ化ナトリウムである場合など、別個の化合物であり得る。 The fluoride ion source and the tin ion source can be the same compound, such as stannous fluoride, which is capable of producing tin and fluoride ions. Additionally, the fluoride ion source and the tin ion source can be separate compounds, such as when the tin ion source is stannous chloride and the fluoride ion source is sodium monofluorophosphate or sodium fluoride.
フッ化物イオン源及び亜鉛イオン源は、亜鉛イオン及びフッ化物イオンを生成することができる、例えば、フッ化亜鉛などの同じ化合物であり得る。加えて、フッ化物イオン源及び亜鉛イオン源は、亜鉛イオン源がリン酸亜鉛であり、フッ化物イオン源がフッ化第一スズである場合など、別個の化合物であり得る。 The fluoride ion source and the zinc ion source can be the same compound, such as zinc fluoride, which is capable of producing zinc ions and fluoride ions. Additionally, the fluoride ion source and the zinc ion source can be separate compounds, such as when the zinc ion source is zinc phosphate and the fluoride ion source is stannous fluoride.
フッ化物イオン源は、フッ化第一スズを本質的に含んでいなくてもよく、又は含んでいなくてもよい。したがって、口腔ケア組成物は、フッ化ナトリウム、フッ化カリウム、フッ化アミン、モノフルオロリン酸ナトリウム、フッ化亜鉛、及び/又はこれらの混合物を含み得る。 The fluoride ion source may be essentially free or free of stannous fluoride. Thus, oral care compositions may include sodium fluoride, potassium fluoride, fluorinated amines, sodium monofluorophosphate, zinc fluoride, and/or mixtures thereof.
口腔ケア組成物は、約50ppm~約5000ppm、好ましくは約500ppm~約3000ppmの遊離フッ化物イオンを提供することができるフッ化物イオン源を含み得る。所望の量のフッ化物イオンを送達するために、フッ化物イオン源は、口腔ケア組成物中に、口腔ケア組成物の約0.0025重量%~約5重量%、約0.01重量%~約10重量%、約0.2重量%~約1重量%、約0.5重量%~約1.5重量%、又は約0.3重量%~約0.6重量%の量で存在し得る。あるいは、口腔ケア組成物は、フッ化物イオン源を0.1%未満、0.01%未満含んでもよい、本質的に含まなくてもよい、実質的に含まなくてもよい、又は含まなくてもよい。 The oral care composition can include a fluoride ion source that can provide about 50 ppm to about 5000 ppm, preferably about 500 ppm to about 3000 ppm of free fluoride ions. To deliver the desired amount of fluoride ions, the fluoride ion source can be present in the oral care composition in amounts ranging from about 0.0025% to about 5%, from about 0.01% to about 5%, by weight of the oral care composition. Present in an amount of about 10%, about 0.2% to about 1%, about 0.5% to about 1.5%, or about 0.3% to about 0.6% by weight. obtain. Alternatively, the oral care composition may contain less than 0.1%, less than 0.01%, essentially free, substantially free, or free of a fluoride ion source. Good too.
金属
本明細書に記載される口腔ケア組成物は、1つ以上の金属イオンを含む金属イオン源によって提供され得る金属を含み得る。金属イオン源は、本明細書に記載されているように、スズイオン源及び/又は亜鉛イオン源を含んでもよい、又はそれに加えられてもよい。好適な金属イオン源としては、Sn、Zn、Cu、Mn、Mg、Sr、Ti、Fe、Mo、B、Ba、Ce、Al、In及び/又はこれらの混合物などであるがこれらに限定されない金属イオンを有する化合物が挙げられる。金属イオン源は、好適な金属並びに任意の付随する配位子及び/又はアニオンを含む任意の化合物であり得る。
Metals The oral care compositions described herein can include metals, which can be provided by a metal ion source that includes one or more metal ions. The metal ion source may include or be added to a tin ion source and/or a zinc ion source, as described herein. Suitable metal ion sources include metals such as, but not limited to, Sn, Zn, Cu, Mn, Mg, Sr, Ti, Fe, Mo, B, Ba, Ce, Al, In and/or mixtures thereof. Examples include compounds having ions. The metal ion source can be any compound containing a suitable metal and any associated ligands and/or anions.
金属イオン源と対をなすことができる好適な配位子及び/又はアニオンとしては、酢酸イオン、硫酸アンモニウムイオン、安息香酸イオン、臭化物イオン、ホウ酸イオン、炭酸イオン、塩化物イオン、クエン酸イオン、グルコン酸イオン、グリセロリン酸イオン、水酸化物イオン、ヨウ化物イオン、シュウ酸イオン、酸化物イオン、プロピオン酸イオン、D-乳酸イオン、DL-乳酸イオン、オルトリン酸イオン、ピロリン酸イオン、硫酸イオン、硝酸イオン、酒石酸イオン、及び/又はこれらの混合物が挙げられるが、これらに限定されない。 Suitable ligands and/or anions that can be paired with the metal ion source include acetate ion, ammonium sulfate ion, benzoate ion, bromide ion, borate ion, carbonate ion, chloride ion, citrate ion, Gluconate ion, glycerophosphate ion, hydroxide ion, iodide ion, oxalate ion, oxide ion, propionate ion, D-lactate ion, DL-lactate ion, orthophosphate ion, pyrophosphate ion, sulfate ion, Examples include, but are not limited to, nitrate ions, tartrate ions, and/or mixtures thereof.
口腔ケア組成物は、約0.01重量%~約10重量%、約1重量%~約5重量%、又は約0.5重量%~約15重量%の金属及び/又は金属イオン源を含み得る。 The oral care composition comprises from about 0.01% to about 10%, from about 1% to about 5%, or from about 0.5% to about 15% metal and/or metal ion source by weight. obtain.
スズ
本発明の口腔ケア組成物は、スズイオン源によって提供され得るスズを含み得る。スズイオン源は、口腔ケア組成物中にスズイオンを提供することができ、及び/又は口腔ケア組成物が口腔に適用されるときに、口腔にスズイオンを供給することができる任意の好適な化合物であり得る。スズイオン源は、フッ化第一スズ、塩化第一スズ、臭化第一スズ、ヨウ化第一スズ、酸化第一スズ、シュウ酸第一スズ、硫酸第一スズ、硫化第一スズ、フッ化第二スズ、塩化第二スズ、臭化第二スズ、ヨウ化第二スズ、硫化第二スズ、及び/又はこれらの混合物などの1つ以上のスズ含有化合物を含み得る。スズイオン源は、フッ化第一スズ、塩化第一スズ、及び/又はこれらの混合物を含み得る。スズイオン源はまた、塩化第一スズなどのフッ化物フリーのスズイオン源であってもよい。
Tin The oral care compositions of the present invention can include tin, which can be provided by a tin ion source. The stannous ion source is any suitable compound capable of providing stannous ions in the oral care composition and/or capable of supplying stannous ions to the oral cavity when the oral care composition is applied to the oral cavity. obtain. The tin ion sources include stannous fluoride, stannous chloride, stannous bromide, stannous iodide, stannous oxide, stannous oxalate, stannous sulfate, stannous sulfide, and fluoride. It may include one or more tin-containing compounds such as stannic, stannic chloride, stannic bromide, stannic iodide, stannic sulfide, and/or mixtures thereof. The stannous ion source may include stannous fluoride, stannous chloride, and/or mixtures thereof. The tin ion source may also be a fluoride-free tin ion source, such as stannous chloride.
口腔ケア組成物は、口腔ケア組成物の約0.0025重量%~約5重量%、約0.01重量%~約10重量%、約0.2重量%~約1重量%、約0.4重量%~約1重量%、又は約0.3重量%~約0.6重量%のスズ及び/又はスズイオン源を含み得る。あるいは、口腔ケア組成物は、スズを本質的に含んでいなくてもよく、実質的に含んでいなくてもよく、又は含んでいなくてもよい。 The oral care composition may contain from about 0.0025% to about 5%, from about 0.01% to about 10%, from about 0.2% to about 1%, about 0.01% to about 1%, by weight of the oral care composition. It may include 4% to about 1% by weight, or about 0.3% to about 0.6% by weight of tin and/or a tin ion source. Alternatively, the oral care composition may be essentially free, substantially free, or free of tin.
亜鉛
本発明の口腔ケア組成物は、亜鉛を含み得、その亜鉛は、亜鉛イオン源によって提供され得る。亜鉛イオン源は、フッ化亜鉛、乳酸亜鉛、酸化亜鉛、リン酸亜鉛、塩化亜鉛、酢酸亜鉛、ヘキサフルオロジルコン酸亜鉛、硫酸亜鉛、酒石酸亜鉛、グルコン酸亜鉛、クエン酸亜鉛、リンゴ酸亜鉛、亜鉛グリシネート、ピロリン酸亜鉛、メタリン酸亜鉛、シュウ酸亜鉛、及び/又は炭酸亜鉛などの1つ以上の亜鉛含有化合物を含み得る。亜鉛イオン源は、リン酸亜鉛、酸化亜鉛、及び/又はクエン酸亜鉛などのフッ化物フリーの亜鉛イオン源であり得る。
Zinc The oral care compositions of the present invention may include zinc, which may be provided by a source of zinc ions. Zinc ion sources include zinc fluoride, zinc lactate, zinc oxide, zinc phosphate, zinc chloride, zinc acetate, zinc hexafluorozirconate, zinc sulfate, zinc tartrate, zinc gluconate, zinc citrate, zinc malate, and zinc. One or more zinc-containing compounds may be included, such as glycinate, zinc pyrophosphate, zinc metaphosphate, zinc oxalate, and/or zinc carbonate. The zinc ion source can be a fluoride-free zinc ion source such as zinc phosphate, zinc oxide, and/or zinc citrate.
亜鉛及び/又は亜鉛イオン源は、全口腔ケア組成物中に、歯磨剤組成物の約0.01重量%~約10重量%、約0.2重量%~約1重量%、約0.4重量%~約1重量%、又は約0.3重量%~約0.6重量%の量で存在し得る。あるいは、口腔ケア組成物は、亜鉛を本質的に含まないか、実質的に含まないか、又は含まないものであり得る。 Zinc and/or a source of zinc ions can be present in the total oral care composition from about 0.01% to about 10%, from about 0.2% to about 1%, from about 0.4% by weight of the dentifrice composition. It may be present in an amount from about 1% to about 1% by weight, or from about 0.3% to about 0.6% by weight. Alternatively, the oral care composition may be essentially free, substantially free, or free of zinc.
ポリホスフェート
口腔ケア組成物は、ポリホスフェート源によって提供され得るポリホスフェートを含み得る。ポリホスフェート源は、1つ以上のポリホスフェート分子を含み得る。ポリホスフェートは、オルトホスフェートの脱水及び縮合によって様々な鎖長の直鎖及び環状ポリホスフェートをもたらすことにより、得られる物質の部類である。したがって、ポリホスフェート分子は、一般に、以下に記載されるように、ポリホスフェート分子の平均数(n)で同定される。ポリホスフェートは一般に、主に直鎖構造に配置された2つ以上のホスフェート分子からなると理解されているが、いくつかの環状誘導体が存在する場合もある。
Polyphosphates Oral care compositions can include polyphosphates, which can be provided by a polyphosphate source. The polyphosphate source may include one or more polyphosphate molecules. Polyphosphates are a class of materials obtained by dehydration and condensation of orthophosphates to yield linear and cyclic polyphosphates of various chain lengths. Therefore, polyphosphate molecules are generally identified by the average number of polyphosphate molecules (n), as described below. Polyphosphates are generally understood to consist of two or more phosphate molecules arranged primarily in a linear configuration, although some cyclic derivatives may also be present.
好ましいポリホスフェートは、有効濃度での表面吸着により十分な非結合のホスフェート官能基を生成し、これがアニオン性表面電荷並びに表面の親水性特徴を強化するように、平均して2つ以上のホスフェート基を有するものである。本発明において好ましいものは、式:XO(XPO3)nX(式中、Xは、ナトリウム、カリウム、アンモニウム、又は任意の他のアルカリ金属カチオンであり、nは、平均約2~約21である)を有する直鎖状ポリホスフェートである。カルシウムなどのアルカリ土類金属カチオンは、フッ化物イオン及びアルカリ土類金属カチオンを含む水溶液から不溶性フッ化物塩を形成する傾向があるため、好ましくない。したがって、本明細書に開示される口腔ケア組成物は、ピロリン酸カルシウムを含まなくてもよい、又は実質的に含まなくてもよい。 Preferred polyphosphates contain an average of two or more phosphate groups such that surface adsorption at an effective concentration produces sufficient unbound phosphate functionality, which enhances the anionic surface charge as well as the hydrophilic character of the surface. It has the following. Preferred in the present invention are those having the formula: XO(XPO 3 ) n It is a linear polyphosphate with a Alkaline earth metal cations, such as calcium, are not preferred because of their tendency to form insoluble fluoride salts from aqueous solutions containing fluoride ions and alkaline earth metal cations. Accordingly, the oral care compositions disclosed herein may be free or substantially free of calcium pyrophosphate.
好適なポリホスフェート分子のいくつかの例としては、例えば、ピロホスフェート(n=2)、トリポリホスフェート(n=3)、テトラポリホスフェート(n=4)、ソーダフォスポリホスフェート(n=6)、ヘキサフォスポリホスフェート(n=13)、ベネフォスポリホスフェート(n=14)、Glass Hとしても知られるヘキサメタホスフェート(n=21)を挙げることができる。ポリホスフェートとしては、FMC Corporation、ICL Performance Products、及び/又はAstarisによって製造されるポリホスフェート化合物を挙げることができる。 Some examples of suitable polyphosphate molecules include, for example, pyrophosphate (n=2), tripolyphosphate (n=3), tetrapolyphosphate (n=4), soda phosphate (n=6), Mention may be made of hexaphospolyphosphate (n=13), benefospolyphosphate (n=14), hexametaphosphate, also known as Glass H (n=21). Polyphosphates can include polyphosphate compounds manufactured by FMC Corporation, ICL Performance Products, and/or Astaris.
口腔ケア組成物は、口腔ケア組成物の約0.01重量%~約15重量%、約0.1重量%~約10重量%、約0.5重量%~約5重量%、約1~約20重量%、又は約10重量%以下のポリホスフェート源を含み得る。あるいは、口腔ケア組成物は、ポリホスフェートを本質的に含まなくてもよい、実質的に含まなくてもよい、又は含まなくてもよい。 The oral care composition may contain from about 0.01% to about 15%, from about 0.1% to about 10%, from about 0.5% to about 5%, from about 1% to about 1%, by weight of the oral care composition. It may include up to about 20%, or about 10% by weight of the polyphosphate source. Alternatively, the oral care composition may be essentially free, substantially free, or free of polyphosphate.
オルトホスフェート
口腔ケア組成物は、オルトホスフェート源によって提供され得るオルトホスフェートを含み得る。オルトホスフェート源は、オルトホスフェートアニオンを含む塩、ホスフェートアニオン(H2PO4
-、HPO4
2-、及びPO4
3-)を含む塩、リン酸化合物、様々な条件下でオルトホスフェートに分解し得るポリホスフェート源、及び/又は別の好適なオルトホスフェート源を含み得る。
Orthophosphate Oral care compositions can include orthophosphate, which can be provided by an orthophosphate source. Orthophosphate sources include salts containing orthophosphate anions, salts containing phosphate anions (H 2 PO 4 − , HPO 4 2− , and PO 4 3− ), phosphoric acid compounds, which decompose to orthophosphate under various conditions. and/or another suitable orthophosphate source.
口腔ケア組成物は、口腔ケア組成物の約0.01重量%~約15重量%、約0.1重量%~約10重量%、約0.5重量%~約5重量%、約1~約20重量%、又は約10重量%以下のオルトホスフェートを含み得る。あるいは、口腔ケア組成物は、オルトホスフェートを本質的に含まなくてもよく、実質的に含まなくてもよく、又は含まなくてもよい。 The oral care composition may contain from about 0.01% to about 15%, from about 0.1% to about 10%, from about 0.5% to about 5%, from about 1% to about 1%, by weight of the oral care composition. It may contain up to about 20%, or about 10% by weight orthophosphate. Alternatively, the oral care composition may be essentially free, substantially free, or free of orthophosphate.
界面活性剤
口腔ケア組成物は、1つ以上の界面活性剤を含み得る。界面活性剤は、組成物をより美容的に許容可能にするために使用することができる。界面活性剤は、好ましくは、組成物に洗浄性及び起泡性を付与する洗浄性材料である。好適な界面活性剤は、安全かつ有効な量のアニオン性、カチオン性、非イオン性、双性イオン性、両性及びベタイン界面活性剤、例えば、ラウリル硫酸ナトリウム、ラウリルイセチオン酸ナトリウム、ラウロイルメチルイセチオン酸ナトリウム、ココイルグルタミン酸ナトリウム、ドデシルベンゼンスルホン酸ナトリウム、ラウロイルサルコシン酸、ミリストイルサルコシン酸、パルミトイルサルコシン酸、ステアロイルサルコシン酸及びオレオイルサルコシン酸のアルカリ金属塩又はアンモニウム塩、モノステアリン酸ポリオキシエチレンソルビタン、イソステアリン酸ポリオキシエチレンソルビタン及びラウリン酸ポリオキシエチレンソルビタン、ラウリルスルホ酢酸ナトリウム、N-ラウロイルサルコシン、N-ラウロイルサルコシン、N-ミリストイルサルコシン、又はN-パルミトイルサルコシンのナトリウム塩、カリウム塩、及びエタノールアミン塩、アルキルフェノールのポリエチレンオキシド縮合物、ココアミドプロピルベタイン、ラウロアミドプロピルベタイン、パルミチルベタイン、ココイルグルタミン酸ナトリウムなどである。ラウリル硫酸ナトリウムが、好ましい界面活性剤である。口腔ケア組成物は、1つ以上の界面活性剤をそれぞれ口腔ケア組成物の約0.01重量%~約15重量%、約0.3重量%~約10重量%、又は約0.3重量%~約2.5重量%の濃度で含み得る。
Surfactants Oral care compositions may include one or more surfactants. Surfactants can be used to make the composition more cosmetically acceptable. Surfactants are preferably detersive materials that impart detersive and foaming properties to the composition. Suitable surfactants include safe and effective amounts of anionic, cationic, nonionic, zwitterionic, amphoteric and betaine surfactants, such as sodium lauryl sulfate, sodium lauryl isethionate, lauroyl methyl ise. Sodium thionate, sodium cocoyl glutamate, sodium dodecylbenzenesulfonate, lauroyl sarcosinate, myristoyl sarcosinate, palmitoyl sarcosinate, alkali metal salts or ammonium salts of stearoyl sarcosinate and oleoyl sarcosinate, polyoxyethylene sorbitan monostearate, Sodium salt, potassium salt, and ethanolamine salt of polyoxyethylene sorbitan isostearate and polyoxyethylene sorbitan laurate, sodium lauryl sulfoacetate, N-lauroyl sarcosine, N-lauroyl sarcosine, N-myristoyl sarcosine, or N-palmitoyl sarcosine , polyethylene oxide condensates of alkylphenols, cocoamidopropyl betaine, lauramidopropyl betaine, palmityl betaine, sodium cocoyl glutamate, and the like. Sodium lauryl sulfate is a preferred surfactant. The oral care composition comprises one or more surfactants, each containing from about 0.01% to about 15%, from about 0.3% to about 10%, or about 0.3% by weight of the oral care composition. % to about 2.5% by weight.
驚くべきことに、アルキルサルフェート界面活性剤及び/又はラウリル硫酸ナトリウムなどのアニオン性界面活性剤の更なる量は、過酸化物安定性の増加をもたらし得ることが見出された。したがって、望ましい組成物としては、口腔ケア組成物の少なくとも約1.5重量%、1.5重量%超、約1.5重量%~約10重量%、又は1.5重量%~約10重量%のアニオン性界面活性剤を含む組成物が挙げられる。 Surprisingly, it has been found that additional amounts of anionic surfactants such as alkyl sulfate surfactants and/or sodium lauryl sulfate can result in increased peroxide stability. Accordingly, desirable compositions include at least about 1.5%, greater than 1.5%, from about 1.5% to about 10%, or from 1.5% to about 10% by weight of the oral care composition. % of anionic surfactant.
アミノ酸
口腔ケア組成物は、アミノ酸を含み得る。アミノ酸は、本明細書に記載されるように、1つ以上のアミノ酸、ペプチド、及び/又はポリペプチドを含み得る。
Amino Acids Oral care compositions can include amino acids. Amino acids can include one or more amino acids, peptides, and/or polypeptides, as described herein.
アミノ酸は、式IIにあるように、アミン官能基、カルボキシル官能基、及びそれぞれのアミノ酸に特異的な側鎖(式IIではR)を含有する有機化合物である。好適なアミノ酸としては、例えば、正又は負の側鎖を有するアミノ酸、酸性又は塩基性の側鎖を有するアミノ酸、極性非荷電側鎖を有するアミノ酸、疎水性側鎖を有するアミノ酸、及び/又はこれらの組み合わせが挙げられる。好適なアミノ酸としては、例えば、アルギニン、ヒスチジン、リジン、アスパラギン酸、グルタミン酸、セリン、スレオニン、アスパラギン、グルタミン、システイン、セレノシステイン、グリシン、プロリン、アラニン、バリン、イソロイシン、ロイシン、メチオニン、フェニルアラニン、チロシン、トリプトファン、シトルリン、オルニチン、クレアチン、ジアミノブタン酸、ジアミノプロピオン酸、これらの塩、及び/又はこれらの組み合わせも挙げられる。 Amino acids are organic compounds that contain an amine functionality, a carboxyl functionality, and a side chain (R in Formula II) specific to each amino acid, as in Formula II. Suitable amino acids include, for example, amino acids with positive or negative side chains, amino acids with acidic or basic side chains, amino acids with polar uncharged side chains, amino acids with hydrophobic side chains, and/or A combination of these can be mentioned. Suitable amino acids include, for example, arginine, histidine, lysine, aspartic acid, glutamic acid, serine, threonine, asparagine, glutamine, cysteine, selenocysteine, glycine, proline, alanine, valine, isoleucine, leucine, methionine, phenylalanine, tyrosine, Also included are tryptophan, citrulline, ornithine, creatine, diaminobutanoic acid, diaminopropionic acid, salts thereof, and/or combinations thereof.
好適なアミノ酸としては、天然起源の又は合成的に誘導される、式Iに記載の化合物が挙げられる。アミノ酸は、R基及び環境に基づいて、双性イオン性であるか、中性であるか、正に帯電するか、又は負に帯電し得る。アミノ酸の電荷、及び特定の官能基が、ある特定のpH条件下でスズと相互作用することができるかどうかは、当業者には周知であろう。 Suitable amino acids include compounds set forth in Formula I, naturally occurring or synthetically derived. Amino acids can be zwitterionic, neutral, positively charged, or negatively charged, based on the R group and the environment. The charge of amino acids and whether certain functional groups can interact with tin under certain pH conditions will be well known to those skilled in the art.
好適なアミノ酸としては、1つ以上の塩基性アミノ酸、1つ以上の酸性アミノ酸、1つ以上の中性アミノ酸、又はこれらの組み合わせが挙げられる。 Suitable amino acids include one or more basic amino acids, one or more acidic amino acids, one or more neutral amino acids, or combinations thereof.
口腔ケア組成物は、口腔ケア組成物の約0.01重量%~約20重量%、約0.1重量%~約10重量%、約0.5重量%~約6重量%、又は約1重量%~約10重量%のアミノ酸を含み得る。 The oral care composition may contain about 0.01% to about 20%, about 0.1% to about 10%, about 0.5% to about 6%, or about 1% by weight of the oral care composition. It may contain from % to about 10% by weight of amino acids.
本明細書で使用するとき、用語「中性アミノ酸」には、天然に存在する中性アミノ酸、例えば、アラニン、アスパラギン、システイン、グルタミン、グリシン、イソロイシン、ロイシン、メチオニン、フェニルアラニン、プロリン、セリン、スレオニン、トリプトファン、チロシン、バリンだけではなく、pH5.0~7.0の範囲の等電点を有する生物学的に許容されるアミノ酸も含まれる。生物学的に好ましい許容可能な中性アミノ酸は、分子中に単一のアミノ基及びカルボキシル基を有するか、又は、物理化学的特性は類似若しくは実質的に類似しているが変更された側鎖を有する官能性誘導体などの、これらの官能性誘導体を有する。更なる実施形態では、アミノ酸は、少なくとも部分的に水溶性であり、25℃で1g/1000mLの水溶液中で7未満のpHを提供する。 As used herein, the term "neutral amino acids" includes naturally occurring neutral amino acids, such as alanine, asparagine, cysteine, glutamine, glycine, isoleucine, leucine, methionine, phenylalanine, proline, serine, threonine , tryptophan, tyrosine, and valine, as well as biologically acceptable amino acids with isoelectric points ranging from pH 5.0 to 7.0. Biologically preferred and acceptable neutral amino acids have a single amino and carboxyl group in the molecule, or have similar or substantially similar physicochemical properties but with altered side chains. These functional derivatives, such as functional derivatives having . In a further embodiment, the amino acid is at least partially water soluble and provides a pH of less than 7 in an aqueous solution of 1 g/1000 mL at 25°C.
したがって、本発明での使用に好適な中性アミノ酸としては、アラニン、アミノ酪酸、アスパラギン、システイン、シスチン、グルタミン、グリシン、ヒドロキシプロリン、イソロイシン、ロイシン、メチオニン、フェニルアラニン、プロリン、セリン、タウリン、スレオニン、トリプトファン、チロシン、バリン、これらの塩、又はこれらの混合物が挙げられるが、これらに限定されない。好ましくは、本発明の組成物において使用される中性アミノ酸としては、アスパラギン、グルタミン、グリシン、これらの塩、又はこれらの混合物を挙げることができる。中性アミノ酸は、25℃の水溶液中で、5.0、又は5.1、又は5.2、又は5.3、又は5.4、又は5.5、又は5.6、又は5.7、又は5.8、又は5.9、又は6.0、又は6.1、又は6.2、又は6.3、又は6.4、又は6.5、又は6.6、又は6.7、又は6.8、又は6.9、又は7.0の等電点を有し得る。好ましくは、中性アミノ酸は、プロリン、グルタミン、又はグリシンから選択され、より好ましくはその遊離形態(すなわち、非複合体型)である。中性アミノ酸がその塩形態である場合、好適な塩としては、提供される量及び濃度において生理学的に許容可能であると考えられる、医薬的に許容される塩であることが当該技術分野において既知である塩が挙げられる。 Accordingly, neutral amino acids suitable for use in the present invention include alanine, aminobutyric acid, asparagine, cysteine, cystine, glutamine, glycine, hydroxyproline, isoleucine, leucine, methionine, phenylalanine, proline, serine, taurine, threonine, Examples include, but are not limited to, tryptophan, tyrosine, valine, salts thereof, or mixtures thereof. Preferably, the neutral amino acids used in the compositions of the invention may include asparagine, glutamine, glycine, salts thereof, or mixtures thereof. Neutral amino acids are 5.0, or 5.1, or 5.2, or 5.3, or 5.4, or 5.5, or 5.6, or 5.7 in an aqueous solution at 25°C. , or 5.8, or 5.9, or 6.0, or 6.1, or 6.2, or 6.3, or 6.4, or 6.5, or 6.6, or 6.7 , or 6.8, or 6.9, or 7.0. Preferably, the neutral amino acid is selected from proline, glutamine, or glycine, more preferably in its free form (ie, uncomplexed). When the neutral amino acid is in its salt form, it is known in the art that suitable salts are pharmaceutically acceptable salts that are considered physiologically acceptable in the amounts and concentrations provided. Examples include known salts.
保湿剤
口腔ケア組成物は、1つ以上の保湿剤を含んでもよい、低濃度の保湿剤を含んでもよい、又は保湿剤を含まなくてもよい。保湿剤は、口腔ケア組成物又は歯磨剤に粘性(body)又は「口当たり」を加えるだけでなく、歯磨剤が乾燥するのを防止する役割を果たす。好適な保湿剤としては、ポリエチレングリコール(様々な異なる分子量で)、プロピレングリコール、グリセリン(グリセロール)、エリスリトール、キシリトール、ソルビトール、マンニトール、ブチレングリコール、ラクチトール、加水分解水添デンプン、及び/又はこれらの混合物が挙げられる。口腔ケア組成物は、それぞれ口腔ケア組成物の0~約70重量%、約5重量%~約50重量%、約10重量%~約60重量%、又は約20重量%~約80重量%の濃度で1つ以上の保湿剤を含み得る。
Humectants The oral care compositions may include one or more humectants, low concentrations of humectants, or no humectants. Humectants not only add body or "mouthfeel" to an oral care composition or dentifrice, but also serve to prevent the dentifrice from drying out. Suitable humectants include polyethylene glycol (in various different molecular weights), propylene glycol, glycerin (glycerol), erythritol, xylitol, sorbitol, mannitol, butylene glycol, lactitol, hydrolyzed hydrogenated starch, and/or mixtures thereof. can be mentioned. The oral care compositions each contain 0 to about 70%, about 5% to about 50%, about 10% to about 60%, or about 20% to about 80% by weight of the oral care composition. Concentrations may include one or more humectants.
増粘剤
口腔ケア組成物は、本明細書に記載されるように、両親媒性ポリマー及びアルキルアルコールに加えて、1つ以上の増粘剤を含み得る。増粘剤は、口腔ケア組成物において、歯磨剤及び/又は練り歯磨きを相分離に対して安定化させるゼラチン構造を提供するのに有用であり得る。好適な増粘剤としては、多糖類、ポリマー、及び/又はシリカ増粘剤が挙げられる。
Thickeners Oral care compositions may include one or more thickeners in addition to the amphiphilic polymer and alkyl alcohol, as described herein. Thickeners can be useful in oral care compositions to provide a gelatin structure that stabilizes the dentifrice and/or toothpaste against phase separation. Suitable thickeners include polysaccharides, polymers, and/or silica thickeners.
増粘剤は、1つ以上の多糖類を含み得る。多糖類のいくつかの非限定例としては、デンプン;デンプンのグリセライト;ガム、例えば、カラヤガム(ステルクリアガム)、トラガカントガム、アラビアガム、ガティガム、アカシアガム、キサンタンガム、グアーガム、及びセルロースガム;ケイ酸アルミニウムマグネシウム(Veegum);カラギーナン;アルギン酸ナトリウム;寒天;ペクチン;ゼラチン、セルロース化合物、例えばセルロース、微結晶性セルロース、カルボキシメチルセルロース、ヒドロキシエチルセルロース、ヒドロキシプロピルセルロース、ヒドロキシメチルセルロース、ヒドロキシメチルカルボキシプロピルセルロース、メチルセルロース、エチルセルロース、及び硫酸化セルロース;天然及び合成粘土、例えば、ヘクトライト粘土;並びにこれらの混合物が挙げられる。 Thickeners may include one or more polysaccharides. Some non-limiting examples of polysaccharides include starch; glycerites of starch; gums such as gum karaya (gum sterculia), gum tragacanth, gum arabic, gum gati, gum acacia, xanthan gum, guar gum, and cellulose gum; aluminum silicate. Magnesium (Veegum); carrageenan; sodium alginate; agar; pectin; gelatin; cellulose compounds such as cellulose, microcrystalline cellulose, carboxymethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, hydroxymethylcellulose, hydroxymethylcarboxypropylcellulose, methylcellulose, ethylcellulose, and sulfated cellulose; natural and synthetic clays, such as hectorite clay; and mixtures thereof.
本明細書において使用するのに好適な他の多糖類としては、カラギーナン、ジェランガム、ローカストビーンガム、キサンタンガム、カルボマー、ポロキサマー、変性セルロース、及びこれらの混合物が挙げられる。カラギーナンは、海藻由来の多糖類である。その海藻源によって区別され得る、及び/又は硫酸化の程度及び位置によって区別され得る複数種類のカラギーナンが存在する。増粘剤としては、κ-カラギーナン、変性κ-カラギーナン、ι-カラギーナン、変性ι-カラギーナン、λ-カラギーナン、及びこれらの混合物を挙げることができる。本明細書での使用に好適なカラギーナンとしては、FMC Companyからシリーズ名「Viscarin」で市販されているものが挙げられ、限定するものではないが、Viscarin TP 329、Viscarin TP 388、及びViscarin TP 389が挙げられる。 Other polysaccharides suitable for use herein include carrageenan, gellan gum, locust bean gum, xanthan gum, carbomer, poloxamer, modified cellulose, and mixtures thereof. Carrageenan is a polysaccharide derived from seaweed. There are multiple types of carrageenan that can be distinguished by their seaweed source and/or by the degree and location of sulfation. Thickeners can include κ-carrageenan, modified κ-carrageenan, ι-carrageenan, modified ι-carrageenan, λ-carrageenan, and mixtures thereof. Carrageenans suitable for use herein include those commercially available from FMC Company under the series name "Viscarin", including, but not limited to, Viscarin TP 329, Viscarin TP 388, and Viscarin TP 389. can be mentioned.
増粘剤は、1つ以上のポリマーを含み得る。ポリマーは、口腔ケア組成物の様々な重量パーセントの、及び様々な範囲の平均分子範囲の、ポリエチレングリコール(polyethylene glycol、PEG)、ポリビニルピロリドン(polyvinylpyrrolidone、PVP)、ポリアクリル酸、少なくとも1つのアクリル酸モノマーから誘導されたポリマー、無水マレイン酸とメチルビニルエーテルとのコポリマー、架橋ポリアクリル酸ポリマーであり得る。あるいは、口腔ケア組成物は、無水マレイン酸とメチルビニルエーテルとのコポリマーを含んでいなくてもよく、本質的に含んでいなくてもよく、又は実質的に含んでいなくてもよい。 Thickeners may include one or more polymers. The polymers include polyethylene glycol (PEG), polyvinylpyrrolidone (PVP), polyacrylic acid, at least one acrylic acid, in varying weight percentages of the oral care composition, and in varying ranges of average molecular ranges. It can be a polymer derived from monomers, a copolymer of maleic anhydride and methyl vinyl ether, a crosslinked polyacrylic acid polymer. Alternatively, the oral care composition may be free, essentially free, or substantially free of maleic anhydride and methyl vinyl ether copolymer.
増粘剤は、1つ以上の無機増粘剤を含み得る。好適な無機増粘剤のいくつかの非限定的な例としては、コロイド状ケイ酸アルミニウムマグネシウム、シリカ増粘剤が挙げられる。有用なシリカ増粘剤としては、例えば、非限定的な例として、ZEODENT(登録商標)165シリカなどの非晶質沈降シリカが挙げられる。他の非限定的なシリカ増粘剤としては、全てEvonik Corporationから入手可能なZEODENT(登録商標)153、163、及び167、並びにZEOFREE(登録商標)177及び265シリカ製品、並びにAEROSIL(登録商標)ヒュームドシリカが挙げられる。 Thickeners may include one or more inorganic thickeners. Some non-limiting examples of suitable inorganic thickeners include colloidal magnesium aluminum silicate, silica thickeners. Useful silica thickeners include, for example, amorphous precipitated silicas, such as, by way of non-limiting example, ZEODENT® 165 silica. Other non-limiting silica thickeners include ZEODENT® 153, 163, and 167, and ZEOFREE® 177 and 265 silica products, all available from Evonik Corporation, and AEROSIL®. Examples include fumed silica.
口腔ケア組成物は、0.01%~約15%、0.1%~約10%、約0.2%~約5%、又は約0.5%~約2%の1つ以上の増粘剤を含むことができる。 The oral care composition may contain one or more of the following: 0.01% to about 15%, 0.1% to about 10%, about 0.2% to about 5%, or about 0.5% to about 2%. It can contain a sticky agent.
ジカルボン酸
口腔ケア組成物は、ジカルボン酸を含み得る。ジカルボン酸は、2つのカルボン酸官能基を有する化合物を含む。ジカルボン酸は、式IIによって定義される化合物又はこの塩を含み得る。
Dicarboxylic Acids Oral care compositions can include dicarboxylic acids. Dicarboxylic acids include compounds with two carboxylic acid functional groups. The dicarboxylic acid may include a compound defined by Formula II or a salt thereof.
Rは、無、アルキル、アルケニル、アリル、フェニル、ベンジル、脂肪族、芳香族、ポリエチレングリコール、ポリマー、O、N、P、又はこれらの組み合わせであり得る。 R can be null, alkyl, alkenyl, allyl, phenyl, benzyl, aliphatic, aromatic, polyethylene glycol, polymer, O, N, P, or combinations thereof.
ジカルボン酸は、シュウ酸、マロン酸、コハク酸、グルタル酸、アジピン酸、ピメリン酸、スベリン酸、アゼライン酸、セバシン酸、ウンデカン二酸、ドデカン二酸、ブラシル酸、タプシン酸、日本酸、フェロゲン酸、エキセトール酸、リンゴ酸、酒石酸、これらの塩、又はこれらの組み合わせを含み得る。ジカルボン酸は、モノアルカリ金属シュウ酸塩、ジアルカリ金属シュウ酸塩、シュウ酸一水素一カリウム、シュウ酸二カリウム、シュウ酸一水素一ナトリウム、シュウ酸二ナトリウム、シュウ酸チタン、及び/又はシュウ酸塩の他の金属塩などの、ジカルボン酸の好適な塩を含み得る。ジカルボン酸はまた、ジカルボン酸の水和物及び/又はジカルボン酸の塩の水和物も含み得る。 Dicarboxylic acids include oxalic acid, malonic acid, succinic acid, glutaric acid, adipic acid, pimelic acid, suberic acid, azelaic acid, sebacic acid, undecanedioic acid, dodecanedioic acid, brassylic acid, thapsic acid, Japanese acid, and ferrogenic acid. , exetolic acid, malic acid, tartaric acid, salts thereof, or combinations thereof. Dicarboxylic acids include monoalkali metal oxalates, dialkali metal oxalates, monopotassium monohydrogen oxalate, dipotassium oxalate, monosodium monohydrogen oxalate, disodium oxalate, titanium oxalate, and/or oxalic acid. Suitable salts of dicarboxylic acids may be included, such as other metal salts. Dicarboxylic acids may also include hydrates of dicarboxylic acids and/or hydrates of salts of dicarboxylic acids.
口腔ケア組成物は、約0.01%~約10%、約0.1%~約15%、約1%~約5%、又は約0.0001~約25%のジカルボン酸を含み得る。 Oral care compositions can include about 0.01% to about 10%, about 0.1% to about 15%, about 1% to about 5%, or about 0.0001 to about 25% dicarboxylic acid.
他の成分
口腔ケア組成物は、以下に記載されるように、着香剤、甘味料、着色剤、防腐剤、緩衝剤、又は口腔ケア組成物での使用に好適な他の成分などの様々な他の成分を含み得る。
Other Ingredients Oral care compositions may contain various ingredients such as flavoring agents, sweeteners, colorants, preservatives, buffering agents, or other ingredients suitable for use in oral care compositions, as described below. may contain other ingredients.
着香剤を口腔ケア組成物に添加してもよい。好適な着香剤としては、冬緑油、ペパーミント油、スペアミント油、クローブバッド油、メントール、アネトール、サリチル酸メチル、ユーカリプトール、カッシア、酢酸1-メンチル、セージ、オイゲノール、パセリ油、オキサノン、α-イリソン、マジョラム、レモン、オレンジ、プロペニルグエトール、桂皮、バニリン、エチルバニリン、ヘリオトロピン、4-cis-ヘプテナール、ジアセチル、パラ-tert-ブチルフェニル酢酸メチル、及びこれらの混合物が挙げられる。清涼剤も風味剤系の一部であってもよい。本組成物に好ましい清涼剤は、N-エチル-p-メンタン-3-カルボキシアミド(商業的に「WS-3」として知られている)のようなパラメンタンカルボキシアミド剤、又はN-(エトキシカルボニルメチル)-3-p-メンタンカルボキシアミド(商業的に「WS-5」として知られている)、及びこれらの混合物である。風味剤系は、一般に組成物中で、口腔ケア組成物の約0.001重量%~約5重量%の濃度で用いられる。これらの着香剤は、一般に、アルデヒド、ケトン、エステル、フェノール、酸、並びに脂肪族アルコール、芳香族アルコール、及び他のアルコールの混合物を含む。 Flavoring agents may also be added to the oral care compositions. Suitable flavoring agents include wintergreen oil, peppermint oil, spearmint oil, clove bud oil, menthol, anethole, methyl salicylate, eucalyptol, cassia, 1-menthyl acetate, sage, eugenol, parsley oil, oxanone, alpha - irisone, marjoram, lemon, orange, propenylguetol, cinnamon, vanillin, ethylvanillin, heliotropin, 4-cis-heptenal, diacetyl, methyl para-tert-butylphenylacetate, and mixtures thereof. Cooling agents may also be part of the flavor system. Preferred cooling agents for the present compositions are para-menthane carboxamide agents such as N-ethyl-p-menthane-3-carboxamide (commercially known as "WS-3"), or N-(ethoxy carbonylmethyl)-3-p-menthanecarboxamide (commercially known as "WS-5"), and mixtures thereof. Flavor systems are generally used in the compositions at concentrations of about 0.001% to about 5% by weight of the oral care composition. These flavoring agents generally include aldehydes, ketones, esters, phenols, acids, and mixtures of aliphatic, aromatic, and other alcohols.
製品に快い味を付与するために、甘味料を口腔ケア組成物に添加してもよい。好適な甘味料としては、サッカリン(サッカリンナトリウム、サッカリンカリウム又はサッカリンカルシウムとして)、チクロ(ナトリウム塩、カリウム塩又はカルシウム塩として)、アセスルファムK、タウマチン、ネオヘスペリジンジヒドロカルコン、アンモニア化グリチルリチン、デキストロース、レブロース、スクロース、マンノース、スクラロース、ステビア、及びグルコースが挙げられる。 Sweeteners may be added to the oral care compositions to impart a pleasant taste to the product. Suitable sweeteners include saccharin (as saccharin sodium, saccharin potassium or saccharin calcium), cyclamate (as sodium salt, potassium salt or calcium salt), acesulfame K, thaumatin, neohesperidin dihydrochalcone, ammoniated glycyrrhizin, dextrose, lebulose, Includes sucrose, mannose, sucralose, stevia, and glucose.
製品の審美的外観を改善するために、着色剤を添加してもよい。好適な着色剤としては、限定するものではないが、FDAなどの適切な規制機関によって承認された着色剤、及び欧州食品医薬品指令に列挙されている着色剤が挙げられ、TiO2などの顔料、並びにFD&C及びD&C染料などの色素を含む。 Colorants may be added to improve the aesthetic appearance of the product. Suitable colorants include, but are not limited to, colorants approved by appropriate regulatory agencies such as the FDA and colorants listed in the European Food and Drug Directive, pigments such as TiO2 , and dyes such as FD&C and D&C dyes.
細菌増殖を防止するために、防腐剤もまた、口腔ケア組成物に添加されてもよい。メチルパラベン、プロピルパラベン、安息香酸、及び安息香酸ナトリウムなどの、口腔用組成物中での使用が承認された適切な防腐剤を、安全かつ有効な量で添加することができる。 Preservatives may also be added to oral care compositions to prevent bacterial growth. Suitable preservatives approved for use in oral compositions, such as methylparaben, propylparaben, benzoic acid, and sodium benzoate, can be added in safe and effective amounts.
二酸化チタンもまた本発明の組成物に加えられてもよい。二酸化チタンは、組成物に不透明度を加える白色粉末である。二酸化チタンは、一般に、口腔ケア組成物の約0.25重量%~約5重量%を構成する。 Titanium dioxide may also be added to the compositions of the invention. Titanium dioxide is a white powder that adds opacity to the composition. Titanium dioxide generally comprises about 0.25% to about 5% by weight of the oral care composition.
減感剤、治癒剤、他の齲蝕予防剤、キレート剤/金属イオン封鎖剤、ビタミン、アミノ酸、タンパク質、他の抗歯垢/抗歯石剤、乳白剤、抗生物質、抗酵素類、酵素類、pH調整剤、酸化剤、酸化防止剤などの他の成分を、口腔ケア組成物中で使用することができる。 Desensitizers, healing agents, other caries prevention agents, chelating agents/sequestering agents, vitamins, amino acids, proteins, other anti-plaque/anti-calculus agents, opacifying agents, antibiotics, anti-enzymes, enzymes, Other ingredients such as pH adjusting agents, oxidants, antioxidants, etc. can be used in the oral care compositions.
水和性口腔ケア組成物
口腔ケア組成物は、水和性口腔ケア組成物であり得る。好適な水和性口腔ケア組成物は、口腔ケア組成物の吐き出し時に、水を与えながら、又は口腔から水分を除去せずに、多量の過酸化物及び/又は他の好適な活性剤を送達することができる。好適な口腔ケア組成物はまた、口腔ケア組成物のシンクへの吐き出し時に、含まれる活性剤、例えば過酸化物の大部分を、シンクではなく口腔に送達することができる口腔ケア組成物を含み得る。
Hydrable Oral Care Compositions The oral care compositions can be hydratable oral care compositions. Suitable hydratable oral care compositions deliver large amounts of peroxide and/or other suitable active agents while imparting water or without removing moisture from the oral cavity upon exhalation of the oral care composition. can do. Suitable oral care compositions also include oral care compositions that, upon spitting of the oral care composition into the sink, can deliver a large portion of the active agent contained therein, such as peroxide, to the oral cavity rather than to the sink. obtain.
好適な口腔ケア組成物としては、歯磨剤組成物、練り歯磨き組成物、及び/又は密集水中油型エマルションが挙げられる。 Suitable oral care compositions include dentifrice compositions, toothpaste compositions, and/or dense oil-in-water emulsions.
多相口腔用組成物
口腔ケア組成物は、多相口腔用組成物を含み得る。多相口腔用組成物は、米国特許出願公開第2018/0133121号、米国特許第10,849,729号、及び/又は米国特許出願公開第10,780,032号などの多相組成物を含むことができ、これらはそれぞれ、参照によりその全体が本明細書に組み込まれる。
Multiphasic Oral Compositions Oral care compositions can include multiphasic oral compositions. Multiphasic oral compositions include multiphasic compositions such as U.S. Patent Application Publication No. 2018/0133121, U.S. Patent Application No. 10,849,729, and/or U.S. Patent Application Publication No. 10,780,032. , each of which is incorporated herein by reference in its entirety.
好適な多相口腔用組成物としては、油中水型エマルション、水中油型エマルション、疎水性相中の可溶性粒子分散体、密集水中油型エマルション、及び/又は密集油中水型エマルションが挙げられる。特に、表5及び表6に記載されているように、密集水中油型エマルションは、高い過酸化物放出率を有する。 Suitable multiphase oral compositions include water-in-oil emulsions, oil-in-water emulsions, soluble particle dispersions in a hydrophobic phase, dense oil-in-water emulsions, and/or dense water-in-oil emulsions. . In particular, as described in Tables 5 and 6, dense oil-in-water emulsions have high peroxide release rates.
従来の水中油型エマルションは、非連続的な疎水性相及び連続的な水相を有する多相組成物である。安定な水中油型エマルションは、少量の疎水性相を多量の水相と組み合わせることによって調製することができる。従来の水中油型エマルションは、連続的な水相内に懸濁及び/又は安定化された疎水性相の非連続的な液滴である。疎水性相と水相とは不混和性であるため、一般に、肉眼で見える分離が生じる前には、疎水性相のほんの少量のみが水相内で安定化され得る。 Conventional oil-in-water emulsions are multiphase compositions with a discontinuous hydrophobic phase and a continuous aqueous phase. Stable oil-in-water emulsions can be prepared by combining a small amount of a hydrophobic phase with a large amount of an aqueous phase. Conventional oil-in-water emulsions are discontinuous droplets of a hydrophobic phase suspended and/or stabilized within a continuous aqueous phase. Because the hydrophobic and aqueous phases are immiscible, generally only a small amount of the hydrophobic phase can be stabilized within the aqueous phase before macroscopic separation occurs.
高内相エマルションは、水中油型又は油中水型エマルションのいずれかであり得、従来のエマルションと比較して、多相組成物の体積又は重量で多量の内部の非連続的な相が存在する。高内相エマルションは、多相組成物の体積又は重量で外部の連続的な相よりも多相組成物の総体積又は総重量でより多くの内部の非連続的な相を有し得る。しかしながら、高内相エマルションの安定性は困難であることを証明することができる。高内相エマルションは、混合時、又は消費者による使用前に高内相エマルションの保管中に肉眼で見える分離を被り得る。 High internal phase emulsions can be either oil-in-water or water-in-oil emulsions, in which there is a large amount of internal discontinuous phase by volume or weight of the multiphase composition compared to conventional emulsions. do. A high internal phase emulsion may have more internal discontinuous phases by total volume or weight of the multiphase composition than external continuous phases by volume or weight of the multiphase composition. However, the stability of high phase emulsions can prove difficult. High internal phase emulsions may undergo visible separation during mixing or during storage of the high internal phase emulsion prior to use by the consumer.
本明細書に記載の密集エマルションは、予想外に安定な高内相エマルションであり得る。高内相エマルションの非連続的な相の濃度が増加するにつれて、非連続的な相の領域は、それらの間の連続的な相の領域で互いに密集し、それらの間の連続的な相の領域で互いに変形することができるように、十分に密集し得る。連続的な相及び非連続的な相の両方が液体である場合、エマルションは、密集による移行が生じると少なくとも部分的に半固体構造に移行し得る。本明細書に記載の密集エマルションは、連続的な相に非連続的な相を少しずつ添加すること、又は徐々に添加すること、又はゆっくりと添加することによって調製することができる。非連続的な相全体を連続的な相に単に組み合わせることにより、必ずしも、密集エマルションがもたらされるわけではない。 The dense emulsions described herein can be unexpectedly stable high internal phase emulsions. As the concentration of discontinuous phases in a high internal phase emulsion increases, the regions of discontinuous phases crowd together with the regions of continuous phase between them, and the regions of continuous phase between them They can be dense enough to be able to deform each other in areas. If both the continuous phase and the discontinuous phase are liquids, the emulsion may at least partially transition to a semi-solid structure when migration due to crowding occurs. The dense emulsions described herein can be prepared by adding the discontinuous phase to the continuous phase in portions, or by gradual addition, or by slow addition. Simply combining the entire discontinuous phase into a continuous phase does not necessarily result in a dense emulsion.
多相口腔ケア組成物及び/又は密集水中油型エマルションは、疎水性相、水相、過酸化物などの活性剤、及び任意選択的に乳化剤を含み得る。 Multiphase oral care compositions and/or dense oil-in-water emulsions may include a hydrophobic phase, an aqueous phase, an active agent such as a peroxide, and optionally an emulsifier.
水相
水相は、少なくとも部分的に連続的、本質的に連続的、又は好ましくは連続的であり得る。多相口腔ケア組成物及び/又は密集水中油型エマルションは、多相口腔ケア組成物及び/又は密集水中油型エマルションの約0.01重量若しくは体積%~約25重量若しくは体積%、約1重量若しくは体積%~約20重量若しくは体積%、約2.5重量若しくは体積%~約20重量若しくは体積%、又は好ましくは約5重量若しくは体積%~約15重量若しくは体積%の水相を含み得る。
Aqueous Phase The aqueous phase may be at least partially continuous, essentially continuous, or preferably continuous. The multiphasic oral care compositions and/or dense oil-in-water emulsions contain from about 0.01% to about 25% by weight or volume, about 1% by weight of the multiphasic oral care compositions and/or dense oil-in-water emulsions. or from about 2.5% to about 20% by weight or volume, or preferably from about 5% to about 15% by weight or volume of the aqueous phase.
水相はまた、例えば、分子量が約200~約20,000の保湿剤を含むポリアルキレングリコール、又はそれらの組み合わせなどの他の水溶性溶媒を含んでもよい。好適な保湿剤としては、一般に、グリセリン、ソルビトール、キシリトール、ブチレングリコール、及びプロピレングリコール、並びにそれらの混合物などの、食用多価アルコールが挙げられる。水相は、水相の少なくとも約10重量若しくは体積%、少なくとも約20重量若しくは体積%、又は少なくとも約30重量若しくは体積%の水を含んでもよい。多相口腔組成物は、任意で乳化剤を含む、過酸化水素などの漂白剤の水溶液を含んでもよい。 The aqueous phase may also include other water-soluble solvents such as, for example, polyalkylene glycols with humectants having a molecular weight of about 200 to about 20,000, or combinations thereof. Suitable humectants generally include edible polyhydric alcohols such as glycerin, sorbitol, xylitol, butylene glycol, and propylene glycol, and mixtures thereof. The aqueous phase may include at least about 10%, at least about 20%, or at least about 30% water by weight or volume of the aqueous phase. Multiphasic oral compositions may include an aqueous solution of a bleaching agent, such as hydrogen peroxide, optionally including an emulsifier.
疎水性相
多相口腔ケア組成物及び/又は密集水中油型エマルションは、疎水性相を含み得る。疎水性相は、少なくとも部分的に非連続的、本質的に非連続的、又は好ましくは非連続的であり得る。
Hydrophobic Phase Multiphase oral care compositions and/or dense oil-in-water emulsions may include a hydrophobic phase. The hydrophobic phase may be at least partially discontinuous, essentially discontinuous, or preferably discontinuous.
多相口腔ケア組成物は、多相口腔ケア組成物又は密集水中油型エマルションの約75重量若しくは体積%~約99重量若しくは体積%、約80重量若しくは体積%~約97.5重量若しくは体積%、約80重量若しくは体積%超、約90重量若しくは体積%超、又は好ましくは約85重量若しくは体積%~約95重量若しくは体積%の疎水性相を含み得る。 The multiphasic oral care composition may contain from about 75% to about 99% by weight or volume, from about 80% to about 97.5% by weight or volume of the multiphasic oral care composition or dense oil-in-water emulsion. , more than about 80% by weight or volume, more than about 90% by weight or volume, or preferably from about 85% to about 95% by weight or volume of the hydrophobic phase.
本明細書に記載の疎水性相の密度は、約0.8g/cm3~約1.0g/cm3、約0.85g/cm3~約0.95g/cm3、若しくは約0.9g/cm3の範囲、又はそのようなより狭い数値範囲が全て本明細書に明示的に記載されているかのように、より狭く、かつそのようなより広い数値範囲内に収まる任意の他の数値範囲であり得る。 The density of the hydrophobic phase described herein is about 0.8 g/cm 3 to about 1.0 g/cm 3 , about 0.85 g/cm 3 to about 0.95 g/cm 3 , or about 0.9 g/cm 3 / cm3 , or any other numerical value that is narrower and falls within such broader numerical range, as if all such narrower numerical ranges were expressly recited herein. It can be a range.
疎水性相は、非毒性の食用油などの、非毒性の油を含み得る。疎水性相は、非毒性の食用油、飽和又は不飽和脂肪アルコール、脂肪族炭化水素、長鎖トリグリセリド、脂肪酸エステル、及びそれらの組み合わせを含み得る。疎水性相はまた、シリコーン、ポリシロキサン、及びそれらの混合物を含んでもよい。疎水性相は、好ましくは鉱油、ワセリン、及びそれらの組み合わせから選択され得る。 The hydrophobic phase may include a non-toxic oil, such as a non-toxic edible oil. The hydrophobic phase may include non-toxic edible oils, saturated or unsaturated fatty alcohols, aliphatic hydrocarbons, long chain triglycerides, fatty acid esters, and combinations thereof. The hydrophobic phase may also include silicones, polysiloxanes, and mixtures thereof. The hydrophobic phase may preferably be selected from mineral oil, petrolatum, and combinations thereof.
乳化剤
多相口腔ケア組成物及び/又は密集水中油型エマルションは、1つ以上の乳化剤を含み得る。多相口腔ケア組成物の設計に応じて、疎水性相は、乳化特性を有し得る。したがって、乳化剤及び疎水性相は、同じ化合物を含み得る。
Emulsifiers Multiphase oral care compositions and/or dense oil-in-water emulsions may include one or more emulsifiers. Depending on the design of the multiphase oral care composition, the hydrophobic phase may have emulsifying properties. Thus, the emulsifier and the hydrophobic phase may contain the same compound.
本明細書に記載の多相口腔ケア組成物及び/又は密集水中油型エマルションは、多相口腔ケア組成物又は密集水中油型エマルションの約0.001重量%~約20重量%、約0.01重量%~約10重量%、最大約10重量%、最大約5重量%、又は好ましくは約0.1重量%~約10重量%の乳化剤を含み得る。 The multiphasic oral care compositions and/or dense oil-in-water emulsions described herein may be from about 0.001% to about 20%, by weight of the multiphasic oral care composition or dense oil-in-water emulsion, from about 0.00% to about 20%, by weight of the multiphasic oral care composition or dense oil-in-water emulsion. 0.1% to about 10%, up to about 10%, up to about 5%, or preferably from about 0.1% to about 10% by weight of emulsifier.
乳化剤として有用な界面活性剤の部類としては、非イオン性、アニオン性、カチオン性、両性、ポリマー性、合成の乳化剤、及びそれらの混合物が挙げられる。多くの好適な非イオン性及び両性界面活性剤は、米国特許第3,988,433号、同第4,051,234号に開示されており、多くの好適な非イオン性界面活性剤もまた、米国特許第3,959,458号に開示されている。 Classes of surfactants useful as emulsifiers include nonionic, anionic, cationic, amphoteric, polymeric, synthetic emulsifiers, and mixtures thereof. Many suitable nonionic and amphoteric surfactants are disclosed in U.S. Pat. No. 3,988,433, U.S. Pat. No. 4,051,234; , U.S. Pat. No. 3,959,458.
乳化剤は、ポリソルベート、アルキルサルフェート、Lipowax(登録商標)D、又はそれらの組み合わせを含み得る。好適なポリソルベート化合物としては、Tween(登録商標)20、40、60、80、又はそれらの組み合わせなどのポリソルベート20、40、60、80、又はそれらの組み合わせが挙げられる。 Emulsifiers may include polysorbates, alkyl sulfates, Lipowax® D, or combinations thereof. Suitable polysorbate compounds include polysorbates 20, 40, 60, 80, or combinations thereof, such as Tween® 20, 40, 60, 80, or combinations thereof.
乳化剤は、アカシア、ゼラチン、レシチン、及びコレステロールなどの天然乳化剤、コロイド粘土、ベントナイト、ビーガム(ケイ酸アルミニウムマグネシウムなどの微細分散固体、及び脂肪酸の塩、ソルビタントリオレエート、ソルビタントリステアレート、サッカロースジステアレート、プロピレングリコールモノステアレート、グリセロールモノステアレート、プロピレングリコールモノラウレート、モノステアリン酸ソルビタン、ソルビタンモノラウレート、ポリオキシエチレン-4-ラウリルエーテル、ラウリル硫酸ナトリウムなどのサルフェート、スルホコハク酸ジオクチルナトリウム、グリセリルエステル、ポリオキシエチレングリコールエステル及びエーテル、ジエチレングリコールモノステアレート、PEG 200ジステアレートなどのスルホネート、並びにソルビタンモノパルミテート、及びそれらのポリオキシエチレン誘導体、モノステアレートなどのポリオキシエチレングリコールエステル、Polysorbate 80(エトキシ化ソルビタンモノオレエート)(Spectrumなどから供給される)などのソルビタン脂肪酸エステル、などの合成乳化剤、並びにこれらの組み合わせを含み得る。
Emulsifiers include natural emulsifiers such as acacia, gelatin, lecithin, and cholesterol, finely dispersed solids such as colloidal clay, bentonite, vegum (magnesium aluminum silicate), and salts of fatty acids, sorbitan trioleate, sorbitan tristearate, sucrose distearate. sulfates, such as propylene glycol monostearate, glycerol monostearate, propylene glycol monolaurate, sorbitan monostearate, sorbitan monolaurate, polyoxyethylene-4-lauryl ether, sodium lauryl sulfate, dioctyl sodium sulfosuccinate, Glyceryl esters, polyoxyethylene glycol esters and ethers, sulfonates such as diethylene glycol monostearate,
乳化剤は、漂白剤と非反応性である界面活性剤であってもよい。例えば、漂白剤と非反応性である界面活性剤は、ヒドロキシ基、窒素基、及び結合部、隣接する炭素原子間の二重若しくは三重共有結合、Znなどの金属、又はそれらの組み合わせを実質的に含まなくてもよい。 The emulsifier may be a surfactant that is non-reactive with bleaching agents. For example, surfactants that are non-reactive with bleach may contain substantially no hydroxy groups, nitrogen groups, and linkages, double or triple covalent bonds between adjacent carbon atoms, metals such as Zn, or combinations thereof. It does not have to be included in
過酸化物放出
好適な口腔ケア組成物としては、口腔内への多量の過酸化物放出を有する口腔ケア組成物が挙げられる。好適な組成物としては、表6に記載される組成物A及びBが挙げられる。他の好適な組成物としては、2分後に少なくとも約0.25%、少なくとも約0.5%、少なくとも約1%、少なくとも約1.5%、少なくとも約2.5%、少なくとも約5%、及び/又は少なくとも約10%の過酸化物拡散%を有する口腔ケア組成物が挙げられる。他の好適な組成物としては、15分後に13%超、少なくとも約15%、少なくとも約25%、又は少なくとも約45%の過酸化物拡散%を有する口腔ケア組成物が挙げられる。
Peroxide Release Suitable oral care compositions include those that have significant peroxide release into the oral cavity. Suitable compositions include compositions A and B listed in Table 6. Other suitable compositions include at least about 0.25%, at least about 0.5%, at least about 1%, at least about 1.5%, at least about 2.5%, at least about 5% after 2 minutes; and/or oral care compositions having a % peroxide diffusion of at least about 10%. Other suitable compositions include oral care compositions that have a % peroxide diffusion after 15 minutes of greater than 13%, at least about 15%, at least about 25%, or at least about 45%.
他の好適な組成物としては、口腔への最初の適用から約120秒以内に、少なくとも約0.25%、少なくとも約0.5%、少なくとも約1%、少なくとも約1.5%、少なくとも約2.5%、少なくとも約5%、及び/又は少なくとも約10%の過酸化物を使用者の口腔内に放出する口腔ケア組成物が挙げられる。他の好適な組成物としては、口腔への最初の適用から約15分以内に、13%超、少なくとも約15%、少なくとも約25%、又は少なくとも約45%の過酸化物を使用者の口腔内に放出する口腔ケア組成物が挙げられる。 Other suitable compositions include at least about 0.25%, at least about 0.5%, at least about 1%, at least about 1.5%, at least about Oral care compositions that release 2.5%, at least about 5%, and/or at least about 10% peroxide into the user's oral cavity are included. Other suitable compositions include delivering more than 13%, at least about 15%, at least about 25%, or at least about 45% peroxide to the user's oral cavity within about 15 minutes of initial application to the oral cavity. oral care compositions that are released into the body.
理論に束縛されるものではないが、本明細書に記載の過酸化物放出率法による過酸化物拡散%が高い組成物は、多量の過酸化物を口腔に放出することも考えられる。 Without wishing to be bound by theory, it is also believed that compositions with high percent peroxide diffusion according to the peroxide release rate method described herein release large amounts of peroxide into the oral cavity.
本発明は、以下の実施例によって更に例示され、これは、いかなる方法であっても本発明の範囲に制限を課すものとして解釈されるべきではない。本明細書の説明を読んだ後に、本発明の趣旨又は添付の特許請求の範囲の範疇から逸脱することなく、それらの様々な他の態様、修正、及び均等物が、当業者に想到され得る。 The invention is further illustrated by the following examples, which should not be construed as imposing a limitation on the scope of the invention in any way. After reading this description, various other embodiments, modifications, and equivalents thereof may occur to those skilled in the art without departing from the spirit of the invention or the scope of the appended claims. .
過酸化物放出
15mLの透析セル(2K MWCO、Slide-A-Lyzer G2 Dialysis Cassette)に、WFI MilliQ水(16グラム)を充填し、キャップを固定した。カセットの片側に、試験製品を適用し、スパチュラで適用した製品を平らにすることによって、セルのプラスチックハウジングによって規定される深さでセル膜表面全体を覆った。1片のパラフィルムを製品組成物上に適用して、サンプリング中のカセット混合中に保護した。セルを、風袋を計った天秤上に製品を下に向けて垂直又は水平に置いた。製品適用後にタイマーを始動させ、カセット内のWFI MilliQ水の試料を規定のタイムポイントで採取した。
Peroxide Release A 15 mL dialysis cell (2K MWCO, Slide-A-Lyzer G2 Dialysis Cassette) was filled with WFI MilliQ water (16 grams) and the cap was secured. The test product was applied to one side of the cassette and the entire cell membrane surface was covered at the depth defined by the cell's plastic housing by leveling the applied product with a spatula. A piece of Parafilm was applied over the product composition to protect it during cassette mixing during sampling. The cell was placed vertically or horizontally with the product facing down on a tared balance. After application of the product, a timer was started and samples of the WFI MilliQ water in the cassette were taken at specified time points.
それぞれの規定のサンプリングポイントにおいて、セルを取り出し、2回180°反転させ、蓋を外し、試料(0.3~0.50g)をピペットで吸引した。サンプリング後、次の試料が必要になるまで、透析セルを天秤に戻した。各試料を、以下に概説するように過酸化物の割合について分析した。 At each defined sampling point, the cell was removed, inverted twice 180°, the lid was removed, and the sample (0.3-0.50 g) was aspirated with a pipette. After sampling, the dialysis cell was returned to the balance until the next sample was required. Each sample was analyzed for peroxide percentage as outlined below.
Reflectoquant RQ Flex過酸化物試験ストリップリーダー(Millipore Sigma)を、0.2~0.20mg/L(604)及び100~1000mg/L(609)試験ストリップ(Supelco)の両方を使用して、過酸化物標準溶液を用いて以下のように較正した。
0.2~20.0mg/Lストリップ:
1. 5グラムの35%過酸化水素を、WFI MilliQ水で合計500グラムに希釈した。
2. 1グラムの(1)を、WFI MilliQ水を使用して500グラムの総重量に希釈した。
3. 2滴の(2)を、0.2~20.0mg/L試験ストリップに5秒間適用し、過剰の溶液をペーパータオル上で軽くたたいた。
4. 試験ストリップを、0.2~20.0mg/L試験ストリッププログラムをロードしたRQ Flex 10に挿入し、測定値を記録した。総ストリップ展開及びプログラムは15秒間であることに留意されたい。5. 2グラムの溶液(1)を、WFI MilliQ水で500グラムに希釈し、工程(3)及び(4)を繰り返した。
100~1000mg/Lストリップ:
1. 0.5グラムの35%過酸化水素を、USP水で合計500グラムに希釈した。
2. 2滴の(1)を、0.2~20.0mg/L試験ストリップに10秒間適用し、過剰の溶液をペーパータオル上で軽くたたいた。ストリップを更に50秒間静置することによって展開した。
3. 試験ストリップを、100~1000mg/L試験ストリッププログラムが残っているRQ Flex 10に10秒間挿入し、測定値を記録した。総ストリップ展開及びプログラムは、この試験ストリップについて約60秒間であったことに留意されたい。
4. 1グラムの35%過酸化水素を、WFI MilliQ水で合計500グラムに希釈した。
5. 試験ストリップを、100~1000mg/L試験ストリッププログラムをロードしたRQ Flex 10に挿入し、測定値を記録した。
Peroxide was measured using a Reflectoquant RQ Flex peroxide test strip reader (Millipore Sigma) with both 0.2-0.20 mg/L (604) and 100-1000 mg/L (609) test strips (Supelco). Calibration was performed using a standard solution as follows.
0.2-20.0mg/L strip:
1. Five grams of 35% hydrogen peroxide was diluted with WFI MilliQ water to a total of 500 grams.
2. One gram of (1) was diluted using WFI MilliQ water to a total weight of 500 grams.
3. Two drops of (2) were applied to the 0.2-20.0 mg/L test strip for 5 seconds and excess solution was dabbed on a paper towel.
4. The test strip was inserted into the RQ Flex 10 loaded with the 0.2-20.0 mg/L test strip program and the measurements were recorded. Note that the total strip development and programming is 15 seconds. 5. 2 grams of solution (1) was diluted to 500 grams with WFI MilliQ water and steps (3) and (4) were repeated.
100-1000mg/L strip:
1. 0.5 grams of 35% hydrogen peroxide was diluted with USP water to a total of 500 grams.
2. Two drops of (1) were applied to the 0.2-20.0 mg/L test strip for 10 seconds and excess solution was dabbed on a paper towel. The strip was developed by letting it sit for an additional 50 seconds.
3. The test strip was inserted into the RQ Flex 10 with the 100-1000 mg/L test strip program remaining for 10 seconds and the reading recorded. Note that the total strip deployment and programming was approximately 60 seconds for this test strip.
4. One gram of 35% hydrogen peroxide was diluted with WFI MilliQ water to a total of 500 grams.
5. The test strip was inserted into the RQ Flex 10 loaded with the 100-1000 mg/L test strip program and the measurements were recorded.
試料の分析
1.所与の試験試料タイムポイントから2滴を、0.2~20.0mg/L又は100~1000mg/Lのいずれかの試験ストリップに適用し、その後、上記で定義した展開時間及び分析工程を行った(a3~a4及びb2~b3)。
2.拡散された過酸化物濃度により、使用する適切なストリップを規定した。濃度がそれぞれのストリップの濃度範囲を超えた場合、連続希釈を行って濃度を範囲内にした。
Sample analysis 1. Apply two drops from a given test sample time point to a test strip of either 0.2-20.0 mg/L or 100-1000 mg/L, followed by development time and analysis steps as defined above. (a3-a4 and b2-b3).
2. The diffused peroxide concentration defined the appropriate strip to use. If the concentration exceeded the concentration range of the respective strip, serial dilutions were performed to bring the concentration within range.
過酸化物放出率を、4つの組成物について決定した。表1の組成物A、及び表2Aの組成物Bは、本発明の組成物である。表3の組成物C及び組成物Dは、Colgate-Palmolive Companyによって販売されている市販製品である。組成物Cは、Colgate Optic White Renewal Toothpasteであり、過酸化水素を3重量%含むとして販売されている。組成物Dは、Colgate Optic White Overnightであり、これも過酸化水素を4重量%含むとして販売されている。 Peroxide release rates were determined for the four compositions. Composition A in Table 1 and Composition B in Table 2A are compositions of the present invention. Composition C and Composition D in Table 3 are commercial products sold by Colgate-Palmolive Company. Composition C is Colgate Optic White Renewal Toothpaste and is sold as containing 3% hydrogen peroxide by weight. Composition D is Colgate Optic White Overnight, also sold as containing 4% hydrogen peroxide by weight.
表1は、密集水中油型エマルションである組成物Aの配合を示す。組成物Aは、ポリソルベート20、水、スクラロース及びH2O2の水溶液を、20ガロンのプレミックスタンク中で混合することによって作製した。プレミックス混合物を400L容器に移し、鉱油を30分かけてゆっくり添加しながら撹拌した。次に着香料を添加し、バッチを5分間撹拌した。水中油型エマルションがこの工程中に形成され、組成物は、ローション様の半固体稠度を生じた。 Table 1 shows the formulation of Composition A, a dense oil-in-water emulsion. Composition A was made by mixing an aqueous solution of polysorbate 20, water, sucralose, and H 2 O 2 in a 20 gallon premix tank. The premix mixture was transferred to a 400 L container and stirred while slowly adding mineral oil over 30 minutes. The flavor was then added and the batch was stirred for 5 minutes. An oil-in-water emulsion was formed during this step and the composition developed a lotion-like semi-solid consistency.
2セチルアルコール:ステアリルアルコール:SLS(45:45:10)
2 Cetyl alcohol: Stearyl alcohol: SLS (45:45:10)
表2Aは、フッ化物、4重量%の過酸化物、水、及び研磨剤を含む歯磨剤組成物である,組成物Bの配合を示す。透析セル中への過酸化物の放出を表5に示し、更に図1に示す。 Table 2A shows the formulation of Composition B, a dentifrice composition containing fluoride, 4% by weight peroxide, water, and an abrasive. The release of peroxide into the dialysis cell is shown in Table 5 and further shown in FIG.
2セチルアルコール:ステアリルアルコール:SLS(45:45:10)
2 Cetyl alcohol: Stearyl alcohol: SLS (45:45:10)
表2Bは、異なる量の両親媒性ポリマー(1.25重量%~2.25重量%)及びアルキルアルコール(0.75重量%~1.25重量%)を含む様々な例示的な組成物を示す。実施例1~6は、モノフルオロリン酸ナトリウム(1.14重量%)、ラウリル硫酸ナトリウム(1.4重量%)、ピロリン酸カルシウム(10重量%)、及び過酸化水素(4重量%)を含む。 Table 2B shows various exemplary compositions containing different amounts of amphiphilic polymer (1.25% to 2.25% by weight) and alkyl alcohol (0.75% to 1.25% by weight). show. Examples 1-6 include sodium monofluorophosphate (1.14% by weight), sodium lauryl sulfate (1.4% by weight), calcium pyrophosphate (10% by weight), and hydrogen peroxide (4% by weight) .
表3は、比較例で市販製品である組成物C、Colgate Optic White Renewal toothpaste、及び組成物D、Colgate Optic White Overnight whitening penの箱に列挙されている成分を示す。 Table 3 shows the ingredients listed on the box of the comparative commercial products Composition C, Colgate Optic White Renewal toothpaste, and Composition D, Colgate Optic White Overnight whitening pen.
表4は、透析セル中の過酸化物の量(ppm)を計算するために利用される手順の例を示す。表4に示すように、組成物Aは、120秒後に717ppmの過酸化物、300秒後に1525ppmの過酸化物、及び900秒後に3263ppmの過酸化物をもたらした。表4に示される定量化の同じ方法を使用して、組成物B、組成物C、及び組成物Dを用いて様々な時間で透析セルの濃度を決定した。 Table 4 shows an example of the procedure utilized to calculate the amount of peroxide (ppm) in a dialysis cell. As shown in Table 4, Composition A yielded 717 ppm peroxide after 120 seconds, 1525 ppm peroxide after 300 seconds, and 3263 ppm peroxide after 900 seconds. Using the same method of quantification shown in Table 4, concentrations in the dialysis cell were determined using Composition B, Composition C, and Composition D at various times.
表5は、規定時間後の組成物A~Dのロード後の各透析セルの過酸化物濃度を示す。表5に示すように、組成物A及び組成物Bは、120秒後に透析セル中にそれぞれ717ppm及び150ppmの過酸化水素をもたらした。組成物C及びDは、120秒後に透析セル中にそれぞれ1ppm及び2pm未満の過酸化物をもたらした。更に、組成物A及び組成物Bは、900秒後に透析セル中にそれぞれ3263ppm及び1529ppmの過酸化物をもたらした。組成物C及び組成物Dは、900秒後に透析セル中にそれぞれ219ppm及び252ppmの過酸化物をもたらした。したがって、両方とも溶液中に過酸化水素を含む組成物A及び組成物Bがロードされた膜は、膜を横切る過酸化水素の送達の増加をもたらした。 Table 5 shows the peroxide concentration of each dialysis cell after loading Compositions AD after specified times. As shown in Table 5, Composition A and Composition B resulted in 717 ppm and 150 ppm hydrogen peroxide, respectively, in the dialysis cell after 120 seconds. Compositions C and D resulted in less than 1 ppm and 2 pm peroxide, respectively, in the dialysis cell after 120 seconds. Additionally, Composition A and Composition B resulted in 3263 ppm and 1529 ppm peroxide, respectively, in the dialysis cell after 900 seconds. Composition C and Composition D resulted in 219 ppm and 252 ppm peroxide, respectively, in the dialysis cell after 900 seconds. Thus, membranes loaded with Composition A and Composition B, both containing hydrogen peroxide in solution, resulted in increased delivery of hydrogen peroxide across the membrane.
表6は、規定の期間後に透析セル中に拡散した過酸化物の相対量を示す。組成物A中の過酸化物の総量の9.3~10.8%が、2分後に透析セル中に拡散した。組成物A中の過酸化物の総量の49%が、15分後に透析セル中に拡散した。組成物B中の過酸化物の総量の1.5%が、2分後に透析セル中に拡散した。組成物B中の過酸化物の総量の16%が、15分後に透析セル中に拡散した。対照的に、組成物C及び組成物Dの0.001%及び0.13%が、2分後に透析セル中に拡散し、組成物C及び組成物Dの2.5%及び13%が、15分後に透析セル中に拡散した。 Table 6 shows the relative amount of peroxide diffused into the dialysis cell after a specified period of time. 9.3-10.8% of the total amount of peroxide in Composition A diffused into the dialysis cell after 2 minutes. 49% of the total amount of peroxide in Composition A diffused into the dialysis cell after 15 minutes. 1.5% of the total amount of peroxide in Composition B diffused into the dialysis cell after 2 minutes. 16% of the total amount of peroxide in Composition B diffused into the dialysis cell after 15 minutes. In contrast, 0.001% and 0.13% of Composition C and Composition D diffused into the dialysis cell after 2 minutes, and 2.5% and 13% of Composition C and Composition D diffused into the dialysis cell after 2 minutes. Diffused into the dialysis cell after 15 minutes.
したがって、過酸化物及び水を含む練り歯磨き組成物及び密集水中油型エマルション組成物などの組成物は、透析セルへの過酸化物の拡散の増加をもたらした。驚くべきことに、組成物A及び組成物Bについて表6に示すように、水を含む組成物中の過酸化物は、高い過酸化物放出率を有し、口腔に水分を与え得ることが見出された。理論に束縛されるものではないが、研磨剤を含む口腔ケア組成物中の残りの成分との反応性を最小限に抑えることによって、過酸化物を水を含む組成物中に配合できると考えられる。 Therefore, compositions such as toothpaste compositions and dense oil-in-water emulsion compositions containing peroxide and water resulted in increased diffusion of peroxide into the dialysis cell. Surprisingly, as shown in Table 6 for Composition A and Composition B, peroxide in compositions containing water has a high peroxide release rate and can moisturize the oral cavity. discovered. Without wishing to be bound by theory, it is believed that peroxides can be incorporated into compositions containing water by minimizing reactivity with the remaining ingredients in oral care compositions containing abrasives. It will be done.
理論に束縛されるものではないが、組成物C及び組成物Dについて表6に示すように、錯化によって安定化され、無水シャーシ内に配置される過酸化物は、健康及び美容上の利益を提供するために利用可能な過酸化物の量をより少なくし得ると考えられる。加えて、無水組成物は脱水させる可能性があり、更なる感受性の課題をもたらす。 Without being bound by theory, as shown in Table 6 for Composition C and Composition D, peroxides stabilized by complexation and placed within an anhydrous chassis have health and cosmetic benefits. It is believed that a lower amount of peroxide can be made available to provide. Additionally, anhydrous compositions can be dehydrating, presenting additional sensitivity issues.
本明細書に開示される寸法及び値は、列挙された正確な数値に厳密に限定されるものとして理解されるべきではない。その代わりに、特に指示されない限り、そのような寸法は各々、列挙された値とその値を囲む機能的に同等な範囲との両方を意味することが意図される。例えば、「40mm」と開示された寸法は、「約40mm」を意味することが意図される。 The dimensions and values disclosed herein are not to be understood as being strictly limited to the precise numerical values recited. Instead, unless otherwise indicated, each such dimension is intended to mean both the recited value and a functionally equivalent range surrounding that value. For example, a dimension disclosed as "40 mm" is intended to mean "about 40 mm."
相互参照される又は関連するあらゆる特許又は特許出願、及び本願が優先権又はその利益を主張する任意の特許出願又は特許を含む、本明細書に引用される全ての文書は、除外又は限定することが明言されない限りにおいて、参照によりその全体が本明細書に組み込まれる。いずれの文献の引用も、本明細書中で開示又は特許請求されるいずれの発明に対する先行技術であるともみなされず、あるいはそれを単独で又は他の任意の参考文献(単数又は複数)と組み合わせたときに、そのようないずれの発明も教示、示唆又は開示するとはみなされない。更に、本文書における用語のいずれの意味又は定義も、参照により組み込まれた文書内の同じ用語の任意の意味又は定義と矛盾する場合、本文書においてその用語に与えられた意味又は定義が適用されるものとする。 All documents cited herein, including any patents or patent applications that are cross-referenced or related, and any patent applications or patents to which this application claims priority or benefit, are excluded or qualified. is incorporated herein by reference in its entirety unless explicitly stated otherwise. Citation of any document shall not be construed as prior art to any invention disclosed or claimed herein, alone or in combination with any other reference(s). In some cases, no such invention shall be deemed to teach, suggest or disclose any such invention. Further, if any meaning or definition of a term in this document conflicts with any meaning or definition of the same term in a document incorporated by reference, the meaning or definition given to that term in this document shall control. shall be
本発明の特定の実施形態を例示及び説明してきたが、本発明の趣旨及び範囲から逸脱することなく様々な他の変更及び修正を行うことができる点は当業者には明白であろう。したがって、本発明の範囲内にある全てのそのような変更及び修正を添付の特許請求の範囲に網羅することが意図される。 Although particular embodiments of the invention have been illustrated and described, it will be apparent to those skilled in the art that various other changes and modifications can be made without departing from the spirit and scope of the invention. It is therefore intended that the appended claims cover all such changes and modifications that fall within the scope of this invention.
Claims (24)
(a)前記口腔ケア組成物の約1重量%~約5重量%の過酸化物と、
(b)前記口腔ケア組成物の約5重量%~約75重量%の水と、を含み、
前記口腔ケア組成物は、過酸化物放出法に従って約120秒以内に、少なくとも約1%の過酸化物を放出する、口腔ケア組成物。 A hydrating oral care composition comprising:
(a) about 1% to about 5% peroxide by weight of the oral care composition;
(b) about 5% to about 75% water by weight of the oral care composition;
An oral care composition, wherein the oral care composition releases at least about 1% peroxide within about 120 seconds according to a peroxide release method.
(a)疎水性相と、
(b)水相と、
(c)過酸化物と、を含み、
前記密集水中油型エマルションは、過酸化物放出法に従って約120秒以内に、少なくとも約1%の過酸化物を放出する、密集水中油型エマルション。 A dense oil-in-water emulsion,
(a) a hydrophobic phase;
(b) an aqueous phase;
(c) peroxide;
The dense oil-in-water emulsion is a dense oil-in-water emulsion that releases at least about 1% peroxide within about 120 seconds according to a peroxide release method.
前記口腔ケア組成物が、
(a)前記口腔ケア組成物の約1重量%~約5重量%の過酸化物と、
(b)前記口腔ケア組成物の約5重量%~約75重量%の水と、を含み、
前記口腔ケア組成物は、過酸化物放出法に従って約120秒以内に、少なくとも約1%の過酸化物を放出する、使用。 Use of an oral care composition for delivering peroxide to the oral cavity, comprising:
The oral care composition comprises:
(a) about 1% to about 5% peroxide by weight of the oral care composition;
(b) about 5% to about 75% water by weight of the oral care composition;
Use wherein the oral care composition releases at least about 1% peroxide within about 120 seconds according to a peroxide release method.
Applications Claiming Priority (17)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202163151091P | 2021-02-19 | 2021-02-19 | |
US202163151096P | 2021-02-19 | 2021-02-19 | |
US202163151099P | 2021-02-19 | 2021-02-19 | |
US63/151,099 | 2021-02-19 | ||
US63/151,096 | 2021-02-19 | ||
US63/151,091 | 2021-02-19 | ||
US202163219929P | 2021-07-09 | 2021-07-09 | |
US63/219,929 | 2021-07-09 | ||
US17/577,405 US20220265533A1 (en) | 2021-02-19 | 2022-01-18 | Hydrating oral care compositions comprising peroxide |
US17/577,399 | 2022-01-18 | ||
US17/577,402 US20220265531A1 (en) | 2021-02-19 | 2022-01-18 | Oral care compositions comprising peroxide and compatible abrasive |
US17/577,402 | 2022-01-18 | ||
US17/577,404 US20220265532A1 (en) | 2021-02-19 | 2022-01-18 | Oral care compositions comprising peroxide and alumina |
US17/577,399 US20220265530A1 (en) | 2021-02-19 | 2022-01-18 | Oral care compositions comprising peroxide and polymer |
US17/577,405 | 2022-01-18 | ||
US17/577,404 | 2022-01-18 | ||
PCT/US2022/070717 WO2022178530A1 (en) | 2021-02-19 | 2022-02-18 | Hydrating oral care compositions comprising peroxide |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2024506028A true JP2024506028A (en) | 2024-02-08 |
Family
ID=80682477
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2023547519A Withdrawn JP2024506028A (en) | 2021-02-19 | 2022-02-18 | Hydrating oral care compositions containing peroxide |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP4294354A1 (en) |
JP (1) | JP2024506028A (en) |
AU (1) | AU2022224687A1 (en) |
CA (1) | CA3211176A1 (en) |
MX (1) | MX2023009461A (en) |
WO (1) | WO2022178530A1 (en) |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3959458A (en) | 1973-02-09 | 1976-05-25 | The Procter & Gamble Company | Oral compositions for calculus retardation |
US3988433A (en) | 1973-08-10 | 1976-10-26 | The Procter & Gamble Company | Oral compositions for preventing or removing stains from teeth |
US4051234A (en) | 1975-06-06 | 1977-09-27 | The Procter & Gamble Company | Oral compositions for plaque, caries, and calculus retardation with reduced staining tendencies |
US20050143274A1 (en) * | 2003-12-17 | 2005-06-30 | Ghosh Chanchal K. | Compositions and methods of delivering bleaching agents to teeth |
US20090081136A1 (en) * | 2007-09-24 | 2009-03-26 | Deepak Sharma | Compositions Useful For Tooth Whitening |
US20130108559A1 (en) * | 2011-11-01 | 2013-05-02 | The Procter & Gamble Company | Hydrogen Peroxide Toothpaste With Improved Stability |
BR112018001056A2 (en) * | 2015-07-28 | 2018-09-11 | Procter & Gamble | buccal compositions containing amps polymers, copolymers or cross-polymers |
KR102644926B1 (en) * | 2016-08-09 | 2024-03-08 | 시므라이즈 아게 | Mixtures containing (E)-3-benzo[1,3]dioxol-5-yl-N,N-diphenyl-2-propenamide |
CA3041448A1 (en) | 2016-10-26 | 2018-05-03 | The Procter & Gamble Company | Tooth whitening |
US10849729B2 (en) | 2019-04-16 | 2020-12-01 | The Procter & Gamble Company | Multi-phase oral care compositions |
MX2021011296A (en) | 2019-04-25 | 2021-10-13 | Procter & Gamble | Oral care compositions for active agent delivery. |
BR112021019723A2 (en) * | 2019-04-25 | 2021-12-14 | Procter & Gamble | Oral treatment compositions for active agent release |
-
2022
- 2022-02-18 MX MX2023009461A patent/MX2023009461A/en unknown
- 2022-02-18 WO PCT/US2022/070717 patent/WO2022178530A1/en active Application Filing
- 2022-02-18 CA CA3211176A patent/CA3211176A1/en active Pending
- 2022-02-18 AU AU2022224687A patent/AU2022224687A1/en active Pending
- 2022-02-18 EP EP22708721.0A patent/EP4294354A1/en not_active Withdrawn
- 2022-02-18 JP JP2023547519A patent/JP2024506028A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP4294354A1 (en) | 2023-12-27 |
MX2023009461A (en) | 2023-08-28 |
AU2022224687A1 (en) | 2023-07-27 |
WO2022178530A1 (en) | 2022-08-25 |
CA3211176A1 (en) | 2022-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2934442B1 (en) | Oral care products comprising a tetrabasic zinc - amino acid - halide complex | |
US6132702A (en) | Oral care compositions comprising chlorite and methods | |
US6077502A (en) | Oral care compositions comprising chlorite and methods | |
JP2005510538A (en) | Dentifrice composition comprising a stable low aqueous phase comprising polyphosphate and an ionic active ingredient | |
WO1999043290A1 (en) | Oral care compositions comprising chlorite and methods | |
JP5894679B2 (en) | Color changing composition | |
JP2024506057A (en) | Oral care compositions containing peroxides and compatible abrasives | |
JP2024506028A (en) | Hydrating oral care compositions containing peroxide | |
US20220265533A1 (en) | Hydrating oral care compositions comprising peroxide | |
JP2023522600A (en) | Toothpaste composition containing silica and surface-active polymer | |
JP2024506885A (en) | Oral care compositions containing peroxide | |
JP2024506058A (en) | Oral care composition containing peroxide and alumina | |
US20220265532A1 (en) | Oral care compositions comprising peroxide and alumina | |
CN116897033A (en) | Moisturizing oral care compositions comprising peroxides | |
US20220265530A1 (en) | Oral care compositions comprising peroxide and polymer | |
CN116887801A (en) | Oral care compositions comprising peroxide and alumina | |
US20220265531A1 (en) | Oral care compositions comprising peroxide and compatible abrasive | |
CN116940327A (en) | Oral care compositions comprising peroxides | |
WO2021226157A1 (en) | Remineralizing oral care compositions comprising tin | |
CN116847821A (en) | Oral care compositions comprising peroxide and compatible abrasive | |
WO2014098817A1 (en) | Oral care composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230804 |
|
A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20240307 |